Outcome in patients with trochanteric and subtrochanteric femoral fractures  :  aspects on surgical methods, quality of life and cognitive function by Miedel, Ricard
 
 
From the Department of Clinical Science and Education, Södersjukhuset 
Karolinska Institutet, Stockholm, Sweden 
 
 
OUTCOME IN PATIENTS WITH 
TROCHANTERIC AND SUBTROCHANTERIC 
FEMORAL FRACTURES 
ASPECTS ON SURGICAL METHODS, QUALITY OF LIFE AND COGNITIVE FUNCTION 
 
 
 
Ricard Miedel 
 
 
 
Stockholm, 2011

 All previously published papers were reproduced with the permission of the publishers. 
 
Published by Karolinska Institutet. Printed by Larserics Digital Print AB 
 
© Ricard Miedel, 2011 
ISBN 978-91-7457-537-8

    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dedicated to the health of the elderly.  

    1
CONTENTS 
Abstract ................................................................................................................3 
List of papers........................................................................................................4 
List of abbreviations ............................................................................................5 
Introduction..........................................................................................................6 
Historical background ..................................................................................6 
History of hip fracture research at Södersjukhuset......................................7 
Epidemiology................................................................................................7 
Classification ................................................................................................8 
Evolution of internal fixation .....................................................................12 
Assessment of outcome..............................................................................19 
Cognitive function ......................................................................................20 
Stating the problem.....................................................................................20 
Aims of the studies.............................................................................................22 
Patients ...............................................................................................................23 
Ethics...........................................................................................................23 
Inclusion criteria and follow-up.................................................................23 
Methods..............................................................................................................25 
Age and gender...........................................................................................25 
Fracture classification.................................................................................25 
Co-morbidity...............................................................................................25 
Randomisation............................................................................................26 
Cognitive function ......................................................................................26 
ADL ............................................................................................................26 
Preoperative walking ability.......................................................................26 
Living conditions........................................................................................26 
Treatment modalities ..................................................................................27 
Perioperative data .......................................................................................27 
Complications.............................................................................................28 
Radiological assessment.............................................................................28 
Assessment of clinical outcome.................................................................29 
Statistical methods......................................................................................32 
Results ................................................................................................................33 
Study I.........................................................................................................33 
Study II .......................................................................................................37 
Study III ......................................................................................................40 
Study IV......................................................................................................44 
Study V .......................................................................................................47 
General discussion .............................................................................................51 
Failure rates and reoperation rates .............................................................51 
Fracture healing complications ..................................................................53 
Wound infections........................................................................................54 
Femoral shaft fractures...............................................................................55 
Salvage procedures.....................................................................................56 
Surgical technique ......................................................................................56 
Hip function ................................................................................................57 
  2 
Musculoskeletal function according to the SMFA.................................... 58 
Quality of life according to the EQ-5D ..................................................... 58 
Assessment of outcome.............................................................................. 59 
Nail or plate? .............................................................................................. 59 
The influence of cognitive function on outcome....................................... 61 
Limitations and strengths ........................................................................... 63 
Conclusions........................................................................................................ 65 
Abstract in Swedish ........................................................................................... 66 
Acknowledgements ........................................................................................... 67 
References.......................................................................................................... 69 
Original papers I - V.......................................................................................... 80 
    3
ABSTRACT 
A hip fracture is a significant cause of increased morbidity and mortality in elderly 
people and Scandinavia presents the highest incidence of hip fractures worldwide. The 
hip fracture is a serious consequence of osteoporosis which demands acute surgery with 
a high risk of complications and a threat to a continued independent living. 
Trochanteric and subtrochanteric femoral fractures constitute approximately 50% of all 
hip fractures.  
The overall aim of the thesis was to evaluate the outcome in patients with stable 
trochanteric (Study II), unstable trochanteric (Studies I and III) and subtrochanteric 
(Studies I and IV) femoral fractures with aspects of the surgical methods, including 
assessments of functional outcome and the health-related quality of life (HRQoL). 
Moreover, the aim was to evaluate whether severe cognitive dysfunction could predict 
functional outcome, HRQoL and mortality (Study V). 
In an RCT, 217 patients, mean age 84, with an unstable trochanteric or subtrochanteric 
fracture were allocated to treatment by either a standard Gamma nail (SGN) or a 
Medoff sliding plate (MSP) (Study I). The SGN showed good results in both unstable 
trochanteric and subtrochanteric fractures. Moreover, the SGN showed a reduced 
number of severe general complications and wound infections compared to the MSP. 
The MSP in the biaxial dynamisation mode had a low failure rate in patients with 
unstable trochanteric fractures but a high failure rate in the smaller group of patients 
with subtrochanteric fractures.  
In a prospective cohort study, 148 patients, mean age 83, with a stable trochanteric 
fracture treated with a sliding hip screw (SHS) were included (Study II). The results 
confirm a favourable outcome after a stable trochanteric fracture treated with an SHS 
with a low reoperation rate and a good functional outcome and only limited 
deterioration in HRQoL.  
In a prospective cohort study, 117 patients, mean age 84, with an unstable trochanteric 
fracture treated with the trochanteric Gamma nail (TGN) were included (Study III). The 
results showed that an unstable trochanteric fracture treated with the TGN had a 
substantially negative impact on the patient’s musculoskeletal function as well as on the 
patient’s HRQoL. The need for revision surgery was low in patients with a 3-part 
fracture, while the reoperation rate among those with 4-part fractures was significantly 
higher. The by far most common fracture complication, i.e. a secondary lag screw 
penetration/cut-out, was successfully treated with a total hip replacement. 
In a prospective cohort study, 53 patients, mean age 82, with a subtrochanteric fracture 
treated with the long Gamma nail (LGN) were included (Study IV). The results showed 
that a subtrochanteric fracture treated with the LGN had a substantially negative impact 
on the patient’s musculoskeletal function as well as on the patient’s HRQoL. However, 
the need for revision surgery was comparatively low. 
In Study V 213 patients from Study I were included. The results showed that a 
systematic use of a validated instrument for assessing cognitive function, the SPMSQ, 
identified patients with severe cognitive dysfunction and effectively predicted their 
outcome regarding walking ability, ADL function and mortality. The results strongly 
suggest that the SPMSQ can be recommended for use in the elderly hip fracture 
population in routine health care.  
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INTRODUCTION  
 
HISTORICAL BACKGROUND 
In a historical flashback one of the first descriptions of a trochanteric fracture was 
given by Astley Cooper, an English surgeon and anatomist, in his treatise from the 
year 1851 as follows:.‘..fracture of the femur through the trochanter major, passes 
obliquely upwards and outwards from the lower portion of the neck but instead of 
traversing the neck completely, it penetrates the base of the trochanter major; the line 
of fracture being such as to separate the femur into two fragments, one of which is 
composed of the head, neck and trochanter major, and the other of the shaft with the 
remaining portions of the femur”1 (Figure 1). 
He was also the first to distinguish between fractures of the neck of the proximal femur 
(intracapsular) and those outside of the joint capsule (extracapsular) through the 
trochanteric level.2 
 
Figure 1. The upper part of the right femur viewed from behind and above. 
 
 
From www.bartleby.com 
 
Cooper recommended treatment such as bed rest, use of crutches or cane and wearing 
an elevated shoe to help hasten the recovery after a trochanteric fracture. The 
diagnosis and treatment of trochanteric fractures were later studied by Dupuytren, 
Malgaigne, Velpeau and Whitman. In 1902 Royal Whitman described the reduction 
and treatment of trochanteric femoral fractures recommending abduction, traction 
under anaesthesia, internal rotation and a spica cast for immobilisation.  
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Healing rates may have been acceptable with non-surgical methods, but mortality and 
morbidity rates were high due to complications such as pneumonia, pressure sores, 
muscle atrophy and thromboembolic complications, all associated with prolonged bed 
immobilisation and inactivity. Another drawback of non-operative treatment was mal-
union of the fracture, resulting in leg shortening and/or malrotation and this in turn 
leading to impaired walking ability. Despite the fact that a number of studies3-6 
demonstrated the advantage of surgery in the treatment of trochanteric fractures, non-
operative treatment still persisted as a standard treatment for many years. Even after 
1949 when Evans described internal fixation and mobilisation of trochanteric fractures 
as a life-saving measure, conservative treatment had its pleaders.7 
 
HISTORY OF HIP FRACTURE RESEARCH AT SÖDERSJUKHUSET 
The first published thesis from Södersjukhuset on hip fractures was presented by Mats 
H Nilsson in 1984 pertaining to the treatment of trochanteric fractures using the Ender 
intramedullary fixation. At that time the use of Ender nails was one of the most 
prevalent methods in the treatment of trochanteric fractures at Södersjukhuset. The year 
after, 1985, Akke Alberts presented his thesis on ‘Radionuclide Scintimetry after 
Femoral Neck Fracture with Special Reference to Prediction of the Healing Course’. 
From the late 1990s a new scientific organisation was gradually built up at the 
Orthopaedic Department Södersjukhuset, Karolinska Institutet, supporting clinical 
research. In 2002  Jan Tidermark published his thesis ‘Quality of Life and Femoral 
Neck Fractures’ thereby contributing to a paradigm shift in Sweden for the treatment of 
displaced femoral neck fractures in elderly patients with primary hip replacement 
instead of internal fixation. Tidermark’s work was continued by Richard Blomfeldt in 
2006 with the thesis ‘Surgical Treatment of Patients with Displaced Femoral Neck 
Fractures’. Three years later (2009) Anders Enocson defended his thesis, ‘Dislocation 
of Hip Arthroplasty in Patients with Femoral Neck Fractures’, analysing factors 
influencing the stability of hip replacement with special reference to the surgical 
approach and emphasising the advantage of using the anterolateral approach to avoid 
dislocations of the prosthesis after hip replacement in patients with femoral neck 
fractures. In 2011 Carl Johan Hedbeck defended his thesis entitled ‘Arthroplasty in 
Patients with Femoral Neck Fractures’, evaluating the different types of arthroplasty in 
the treatments of patients with displaced femoral neck fractures. As a result of this 
continuous scientific work, a treatment algorithm for patients with femoral neck 
fractures has been introduced. 
 
EPIDEMIOLOGY 
Trochanteric (pertrochanteric/intertrochanteric) as well as subtrochanteric fractures 
belong to the group of proximal femoral fractures, i.e. hip fractures, an entity to which 
also femoral neck fractures is subordinated. Femoral neck fractures constitute 51%, 
trochanteric fractures 38% and subtrochanteric fractures 8% of all hip fractures8 
(Figure 2). The basocervical fracture is a rare fracture in the transition zone between 
the femoral neck and the trochanteric region constituting only 3% of all hip fractures.8 
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1. Femoral neck fractures 
(intracapsular) 
 
 
Figure 2. Hip fractures. 
 
 
 
 
 
 
                                                                       
                                                              
                                                                               
  
 
 
 
 
 
 
 
 
Ortopedi, U Lindgren, O Svensson, 3 ed, Liber Stockholm. With the permission of the authors 
 
According to the Swedish National Hip Fracture Registry (2009),8 the proportion of  
trochanteric fractures appears to increase at the expense of femoral neck fractures. 
 
CLASSIFICATION  
In managing fractures in general, it is important to have a reliable classification system. 
A valid fracture classification should be simple enough to provide guidelines for 
clinical treatment, comprehensive enough to be used in clinical outcome studies and 
reasonably reliable and reproducible.9,10  
In order to classify trochanteric fractures, several classification systems have been 
published. Most of the classifications are based on the anatomical description of the 
fracture patterns observed,7,11 while others are designed to provide prognostic 
information on the prospect of achieving and maintaining reduction12 or are based on 
the fracture mechanism.13 
One of the most frequently used ones is the Jensen-Michaelsen classification 
system,14 which is a modification of the Evans classification.7 The modified grading 
proposed by Jensen and Michaelsen was intended to improve the predictive value of 
the Evans system and to indicate which fractures could be reduced anatomically and 
which were unstable with a risk of secondary displacement.  
 
 
 
 
2. Trochanteric fractures 
(extracapsular) 
3. Subtrochanteric fractures 
(extracapsular) 
 1
 2
 3
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The following fracture types can be identified (Figure 3): 
 
1. The undisplaced 2-part 
fracture (J-M 1). 
2. The displaced 2-part fracture 
(J-M 2). 
3. The 3-part fracture with a 
fracture of the greater 
trochanter (J-M 3). 
4. The 3-part fracture with a 
fracture of the lesser 
trochanter (J-M 4). 
5. The 4-part fracture with a 
fracture of both the greater 
and lesser trochanter (J-M 5). 
 
 
 
 
Figure 3. The Jensen-Michaelsen 
classification for trochanteric 
fractures.14   
 
 
Ortopedi, U Lindgren, O Svensson, 3 ed, Liber Stockholm.  With the permission of the authors. 
 
 
According to the Jensen-Michaelsen classification, the undisplaced 2-part fracture 
and the displaced 2-part fracture (J-M 1 and 2) are defined as stable. The 3- and 4-
part fractures with a fracture of the lesser, the greater or both trochanters (J-M 3-5), 
are defined as unstable. 
The subtrochanteric region of the femur is defined as the region between the lesser 
trochanter and 5 cm distal to it with or without extensions into the trochanteric region.  
One of the most frequently used classifications is the Seinsheimer classification.15  
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The following fracture types can be identified (Figure 4):  
1. The non-displaced fracture with less than 2 mm of displacement of the fracture 
fragments (S1). 
2. The displaced 2-part fracture, which can be classified into the following 
subgroups:  
2A: the transverse 2-part fracture (S2A) 
2B: the spiral 2-part fracture with the lesser trochanter attached to the 
    proximal fragment (S2B) 
2C: the spiral 2-part fracture with the lesser trochanter attached to the   
    distal fragment (S2C) 
3. The 3-part fracture, which can be classified into the following subgroups: 
3A: the spiral 3-part fracture in which the lesser trochanter is a part of the  
     3rd fragment which has an inferior spike of the cortex of varying length 
     (S3A)  
3B: the spiral 3-part fracture in which the lesser trochanter is not a part of  
    the 3rd fragment (S3B) 
4. The comminuted fracture with 4 or more fragments (S4) 
5. The subtrochanteric fracture with an extension through the greater trochanter 
(S5) 
       
Figure 4. The Seinsheimer classification for subtrochanteric fractures.15  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ortopedi, U Lindgren, O Svensson, 3 ed, Liber Stockholm. With the permission of the authors. 
 
 
According to the Seinsheimer classification, the 2-part fractures (S1 and S2) are 
defined as potentially unstable. The 3-part fractures and the comminuted fractures 
(S3-S5) are defined as unstable. 
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Another relatively frequently used classification is the OTA classification,16 which was 
developed from the AO classification.17 This classification can be used to classify both 
trochanteric and subtrochanteric fractures (Figure 5).  
 
Figure 5. The OTA classification for trochanteric and subtrochanteric fractures.16 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      From www//ota.org/compendium 
 
In a comparison between the Jensen-Michaelsen and the AO classification systems for 
trochanteric fractures, van Embden et al.18 reported a moderate inter- and intra-observer 
reliability for the Jensen-Michaelsen classification with kappa values of 0.48 and 0.56, 
respectively, while the inter- and intra-observer reliability for the AO classification was 
considered poor with kappa values of  0.40 and 0.43, respectively.  Unsatisfactory 
inter- and intra-observer reliability for the AO classification has also been reported by 
Schipper and co-workers19 with kappa values of 0.33/0.34 and 0.48, respectively.  
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Also the reliability of the Seinsheimer classification for subtrochanteric fractures has 
been questioned.20 However, in a review of the literature by Loizou et al. (2010),21 the 
authors identified 15 different classification systems for subtrochanteric fractures and 
pointed out that the Seinsheimer classification was the most frequently used one 
followed by the AO classification. The other reviewed classification systems were used 
to a much lesser extent. 
In conclusion, there is not yet an ideal classification system for trochanteric and 
subtrochanteric fractures. In this thesis we have opted to use two of the most frequently 
used ones, in Studies I, II, III and V, the Jensen-Michaelsen classification14 for 
trochanteric fractures and in Studies I, IV and V, the Seinsheimer classification15 for 
subtrochanteric fractures. In Study IV the OTA classification16 was added as a 
complement. 
 
EVOLUTION OF INTERNAL FIXATION 
As early as in 1850, Langenbeck tried to reduce and fix a fracture with the use of an 
intramedullary nail, a treatment very difficult without the availability of preoperative 
radiographs and a perioperative X-ray image intensifier. The development of different 
fixation devices has accelerated during the last 70 years. For trochanteric fractures, the 
development was at first focused on different types of extramedullary devices, i.e. 
plates, and later also on intramedullary devices, i.e. nails. 
 
Extramedullary fixation 
Rigid nail-plate systems were described by Thornton in 1937 and a one-piece nail-plate 
was introduced by Jewett in 1941 with a fixed angle between the blade to be introduced 
into the femoral neck and head and a side-plate to be fixed with screws onto the lateral 
cortex of the femur. In 1947 McLaughlin22 introduced an evolution of this concept 
which allowed various blade-plate angles. However, there were problems with this 
concept since the system did not allow sliding compression along the femoral neck, 
which resulted in a high frequency of penetration of the femoral head into the 
acetabular joint. The honour for the invention of a system that allowed compression 
(dynamisation) along the femoral neck and thereby impaction of the fracture was 
ascribed to Ernst Pohl, an engineer in the local hospital of Kiel, Germany.23 The Pohl 
device was later modified and today there are a number of implants based on his 
principle referred to as the sliding hip screw (SHS). Most of the implants utilise a screw 
introduced into the femoral head, but some use a nail and, more recently, a spiral blade. 
One of the most frequently used SHSs is the dynamic hip screw (DHS; Figure 6) 
which was used in Study II of this thesis.  
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Figure 6. The DHS used in a trochanteric fracture 
allowing compression along the femoral neck 
(arrow). 
 
 
 
 
 
 
 
 
 
 
 
 
A more recent evolution of the SHS is the Medoff sliding plate (MSP) introduced by 
Robert J. Medoff in 1990.24 This system allows sliding both along the femoral neck  
and the femoral shaft (biaxial dynamisation). Moreover, the system allowed the 
surgeon to lock the dynamisation along the femoral neck (uniaxial dynamisation) in 
subtrochanteric fractures in order to prevent medialisation of the femoral shaft, which 
is considered to be a particular problem when using plate fixation in some 
subtrochanteric fractures and unstable trochanteric fractures. 
However, uniaxial dynamisation should only be utilised in 
subtrochanteric fractures solely located below the barrel of the 
plate, otherwise there is a high risk of lag-screw penetration. In 
clinical practice, the differentiation between low trochanteric 
fractures and high subtrochanteric fractures may be difficult 
and lead to erroneous uniaxial dynamisation in trochanteric 
fractures, and uniaxial dynamisation therefore requires 
frequent radiographic follow-ups and readiness for staged 
dynamisation in a number of cases to prevent lag-screw 
penetration.25 The MSP in the biaxial dynamisation mode was 
used in Studies I and V of this thesis (Figure 7).  
. 
 
 
 
 
Figure 7. The MSP in the biaxial dynamisation mode used in a 
subtrochanteric fracture so as to allow compression along both 
the femoral neck and the femoral shaft (arrows). 
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Intramedullary fixation 
An early intramedullary method for the treatment of trochanteric fractures was the 
Ender technique26,27 with closed reduction and fixation with multiple C-formed solid 
nails inserted from the medial condyle and spreading in the femoral head.  The 
technique was popularised during a short period of time and acceptable outcomes, 
compared with the fixed angled nail plates, were reported. However, the technique had 
several draw-backs, e.g. intraoperative fractures at the entry site, lack of optimal 
fixation leading to displacement into varus and external rotation and distal sliding of the 
nails, resulting in knee pain and frequent reoperations.28-31 The technique was 
abandoned by many surgeons when the SHS was introduced. However, the theoretical 
advantages of closed reduction and intramedullary nailing, i.e. potentially reduced 
surgical trauma, reduced blood loss and a reduced infection rate, inspired further 
evolution of the intramedullary nailing technique for trochanteric fractures.  
The principle per se was attractive and a new nail concept was developed at the 
Strasbourg Centre of Traumatology and Orthopaedic Surgery. The principle of this new 
nail with a biomechanical advantage in the form a shorter lever arm is illustrated in 
Figure 8. 
 
Figure 8. The different biomechanical properties comparing the intramedullary nail 
with the extramedullary plate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Initially, there were several biomechanical and technical problems during the 
development of the nail, e.g. inadequate screw diameter, only one angle available, 
problems with sliding of the lag screw, etc. Many changes were made in the light of the 
biomechanical test results, and the insertion of the first clinical prototype of the Gamma 
nail was performed in December 1986 according to G.Taglang. 
The Gamma-style nails with a reinforced proximal section that allows fixation in the 
femoral head and neck region with a larger lag screw and designed for insertion at the 
tip of the greater trochanter are referred to as cephalomedullary nails. This group of 
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nails includes a number of nail designs from different producers, including the 
proximal femoral nail (PFN, PFNA), the Intra-medullary hip screw (IMHS) and the 
standard Gamma nail (SGN), as well as later designs of the Gamma nail, i.e. the 
trochanteric Gamma nail (TGN) and the long Gamma nail (LGN). The evolution of 
the short Gamma nails is displayed in Figure 9. 
 
Figure 9. The evolution of the short Gamma nail. 
 
 
 
The first generation of the Gamma nail, the SGN, with a 
diameter of 11 mm, length of 200 mm, valgus bend of 10° and 
neck angle of 125º or 130º, was used in patients with unstable 
trochanteric fractures (J-M 3–5)14 and high subtrochanteric 
fractures15 in Studies  I and V (Figure 10).  
 
 
 
 
 
 
 
Figure 10. The SGN used in a patient with an unstable 
trochanteric fracture. 
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The early studies on the SGN reported a high frequency of intra- or postoperative 
fractures of the femur,32-34 which forced many surgeons to abandon the implant. 
Retrospectively, this particular problem was probably due to a combination of 
suboptimal design of the nail and, probably even more important, a suboptimal 
surgical technique. The length of the SGN (200 mm) in combination with 10º of 
valgus created a three-point fixation of the non-elastic implant within the proximal 
femur, leading to a concentration of stress at the distal part of the implant.35,36 
Furthermore, the reporting on the work of the participating surgeons in many of the 
studies on the SGN included the surgeons’ learning curve33,37 and an inadequate and 
traumatic surgical technique was sometimes used for insertion of the nail and the 
distal locking screw.  
The second generation Gamma nail, the TGN, with 
a diameter of 11 mm, length of 180 mm, valgus 
bend of 4º and neck angle of 125º or 130º, was used 
in patients with unstable trochanteric fractures (J-M 
3-5)14 in Study III (Figure 11).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. The TGN used in a patient with an 
unstable trochanteric fracture. 
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This second generation nail in combination with improved 
surgical technique has reduced, or possibly eliminated, the 
problem of iatrogenic femoral fractures.  
Recently, after the start of the studies in this thesis, an 
additional evolution of the Gamma nail has been introduced, 
i.e. the Gamma3 nail (Figure 12). This design includes a 
self-tapping thread of the lag-screw, a thinner diameter (5 
mm) of the distal locking screw and a titanium alloy. 
 
 
 
 
 
 
 
 
Figure 12. The Gamma3 used in a patient with an unstable 
trochanteric fracture. 
 
 
 
The long Gamma nail (LGN) designed for use in patients with subtrochanteric 
fractures15 was used in Study IV (Figure 13).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. The LGN 
used in a patient with a 
subtrochanteric fracture. 
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The optimal treatment, extramedullary or intramedullary fixation, of trochanteric and 
subtrochanteric fractures is still a matter of dispute, especially in the group of patients 
with unstable trochanteric fractures. At the time when the first study of this thesis 
(Study I) was started (October, 1998), the cephalomedullary nails were questioned 
primarily due to the reported high incidence of iatrogenic femoral fractures. However, 
since then, improved implant design and improved surgical technique have probably 
resolved this particular problem. Bhandari et al.38 performed a meta-analysis to identify 
the risk of femoral shaft fracture associated with the Gamma nails following treatment 
of extracapsular hip fractures. They found that in previous studies (1991–2000), the risk 
of femoral shaft fracture increases by 4.5 times when compared with the use of the 
SHS. However, in more recent studies (2000-2005), the Gamma nail was not associated 
with a significantly increased risk of femoral shaft fracture.  
 
Fracture complications 
The most frequent fracture complications after trochanteric fractures are lag-screw 
penetration (cut-out) due to varus collapse of the fracture (Figure 14) and excessive 
medialisation of the femoral shaft, the latter seen in unstable trochanteric and 
subtrochanteric fractures treated with extramedullary fixation devices (Figure 15). 
Non-union after a trochanteric fracture is a rare complication, but it is seen more often 
in subtrochanteric fractures (Figure 16).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Lag-screw penetration (cut-out) due to 
varus collapse after an unstable trochanteric fracture 
treated with a TGN. 
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ASSESSMENT OF OUTCOME 
In order to be able to improve treatment methods and to assess the impact of the 
injury/disease upon the patients’ overall function, there is a need for validated 
outcome instruments.  In studies on the treatment of injuries and diseases of the hip, 
the outcome is frequently reported using basic measures such as range of motion, 
fracture healing and the need for revision surgery. Additionally, the functional 
outcome is often reported using region-specific outcome instruments such as 
Charnley´s numerical classification.39 Two major disadvantages of many of these 
specific instruments is that they do not allow a comparison of the outcome in patients 
with different or multiple injuries/diseases of the musculoskeletal system and they are 
not self-reported, i.e. they do not report the outcome from the patients’ own 
perspective.  
The Short Musculoskeletal Function Assessment (SMFA)40 allows a comparison 
between patients with all types of musculoskeletal injuries and diseases, including 
multiple injuries. SMFA is one of the outcome measures developed in collaboration 
with the American Academy of Orthopaedic Surgeons and has been translated and 
validated for several languages, including Swedish.41 
The SMFA does not, however, allow a comparison of patients with injuries/diseases 
outside the musculoskeletal system. Therefore, the outcome is preferably reported with 
the inclusion of an assessment of the HRQoL, which offers an opportunity to compare 
the outcome with patients suffering from injuries/diseases not solely affecting the 
musculoskeletal system.  
Reporting the patients’ own assessment of their HRQoL will contribute to a more 
complete picture of how the injury/disease influences all areas of life and thereby 
Figure 15. Medialisation 
of the shaft after a 
subtrochanteric fracture 
treated with an MSP. 
Figure 16. Non-union 
in a subtrochanteric 
fracture with a fatigue 
breakage of the LGN. 
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enhance our ability to improve future healthcare programmes. The EuroQol (EQ-
5D)42 is a non-disease-specific instrument for describing and evaluating the HRQoL. 
The instrument comprises several dimensions and can be used across different patient 
populations. Moreover, the EQ-5D incorporates preferences for evaluating the health 
states and produces a single index (EQ-5D index score) that can also be used to 
construct quality-adjusted life years (QUALYs).  
The SMFA was used in Studies III and IV and the EQ-5D was used in all studies in this 
thesis. 
  
COGNITIVE FUNCTION 
Delirium (acute confusional state) and dementia are two common risk factors in 
patients with hip fractures. Furthermore, dementia is one of the most common risk 
factors for delirium and the two conditions often co-exist.43-46 A common 
denominator for both of these conditions is the presence of cognitive dysfunction. 
Cognitive dysfunction is defined as a disturbance in the patient’s mental processes 
related to thinking, reasoning and judgement. Previous studies indicate that patients 
with impaired cognitive function have an increased risk for general as well as 
fracture-related complications,47 problems in assimilating rehabilitation,48 prolonged 
hospital stay,46 poor long-term outcome46,49,50 and an increased mortality rate.49,51 
Besides measures to prevent and treat the delirium,52 a thorough understanding of the 
hip fracture patient’s ability to co-operate and follow postoperative regimens is 
crucial in the planning of the surgical treatment and postoperative rehabilitation.  
Despite this knowledge, an assessment of cognitive function is still lacking in nursing 
and medical records for a substantial number of older people with hip fractures.53,54 
Moreover, the routine assessment often differs from the assessment obtained by the 
use of a validated instrument, especially in patients with impaired cognitive ability. In 
a published study, the ward nurses’ assessment correctly identified only 58% of 
patients with impaired cognitive function.53  
The systematic use of a validated instrument has the potential to improve the 
assessment of cognitive function and also entails the possibility of establishing robust 
criteria for identifying the most vulnerable patients and thereby facilitating optimal 
treatment and rehabilitation.  
In Study V we evaluated whether severe cognitive dysfunction, assessed with a 
validated instrument, the Short Portable Mental Status Questionnaire (SPMSQ),55 
could predict the outcome regarding function, the health-related quality of life 
(HRQoL) and mortality in elderly patients with hip fractures. 
  
STATING THE PROBLEM 
In the middle of the 20th century Sweden had a population of approximately 7 million 
people. Today the number of inhabitants in Sweden has reached 9 455 000 and, 
according to the prognosis, the 10-million barrier will be broken in 2024.56 The life 
expectancy for women is assumed to increase from 83 years in 2008 to 87 years in 
2060 and the corresponding figures for men are 79 and 85 years. The constantly 
increasing life expectancy affects the age structure with a steady growth of the group of 
elderly in the population. In today's Sweden 1.6 million people are aged 65 years and 
older, thus constituting 18% of the population and, according to the estimations, the 
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corresponding figures for the year 2060 will be 2.7 million constituting 25% of the 
population.56  
The statistical foundation for the future demographics combined with each person’s 
life-time risk of having a fragility fracture clearly demonstrates the huge public health 
problem we are facing. Growing populations with longer life expectancies and the 
increased proportion of elderly will result in increased suffering and costs related to 
osteoporosis. Among fragility fractures, hip fractures are considered the most serious in 
terms of cost and morbidity and there has been a constant increase in the annual 
number of hip fractures worldwide. According to a recent prognosis, the number of 
patients with hip fractures per year will rise to 2.6 million in 2025 and further to 6.26 
million in 2050. Scandinavia still has the highest incidence of hip fractures in the 
world,57-60 but the most considerable increase will take place in Asia and Latin 
America.57,61-63 However, while there are some studies indicating a trend break,58,59,64-69  
hip fractures are considered to become a progressively larger public health burden.70 
A hip fracture represents probably the most devastating consequence of osteoporosis 
and a mild trauma in terms of mortality, morbidity, disability, quality of life and 
hospital care and cost. For the patient it is not only a difficult physiological trauma, but 
also a psychological trauma that threatens continued autonomy. The fear of sustaining a 
hip fracture with loss of independence is great among elderly people in the community, 
which was clearly demonstrated in the study  by Salkeld et al.71 from 2000 where 80% 
of old women expressed the opinion they would rather die than suffer from a hip 
fracture with a bad outcome. 
The quality of care of older people with hip fractures demands even more attention and 
improvements in treatment are necessary, including preoperative assessment, surgical 
method and postoperative rehabilitation. The overall aim of this thesis was to contribute 
to evidence-based treatment algorithms for the different types of trochanteric and 
subtrochanteric femoral fractures, including studies reporting the outcome with patient-
assessed functional outcome measures including HRQoL. 
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AIMS OF THE STUDIES 
 
 
Study I 
The primary aim was to compare the outcome in patients with unstable trochanteric 
and subtrochanteric fractures randomised to internal fixation with the SGN or the 
MSP in an RCT with a one-year follow-up. The secondary aim was to describe the 
HRQoL according to the EQ-5D within in this group of patients. 
 
 
Study II 
The aim of this study was to report the long-term outcome for patients with stable 
trochanteric fractures treated with an SHS with special regard to the HRQoL in a 
prospective cohort study with a two-year follow-up. 
 
 
Study III 
The primary aim was to report the outcome using the SMFA and, secondly, to report 
the HRQoL according to the EQ-5D after an unstable trochanteric fracture treated with 
a cephalomedullary nail in a prospective cohort study with a one-year follow-up. 
 
 
Study IV 
The primary aim was to report the outcome using the SMFA and, secondly, to report 
the HRQoL according to the EQ-5D after a subtrochanteric fracture treated with a 
cephalomedullary nail in a prospective cohort study with a one-year follow-up. 
 
 
Study V 
The primary aim was to evaluate whether severe cognitive dysfunction, assessed with 
a validated instrument, the SPMSQ, could predict the outcome regarding function, 
HRQoL and mortality in elderly patients with hip fractures within the context of an 
RCT with a one-year follow-up. The secondary aim was to describe the background 
data in relation to cognitive function. 
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PATIENTS 
 
ETHICS 
All studies were conducted according to the Helsinki Declaration and the separate 
protocols were approved by the local Ethics Committee. In Studies II, III and IV, where 
only patients without severe cognitive dysfunction (SPMSQ ≥ 3) were included ,and 
with regard to the patients without severe cognitive dysfunction (SPMSQ ≥ 3) in 
Studies I and V, all patients gave their informed consent to participate. In Studies I and 
V where also patients with severe cognitive dysfunction (SPMSQ < 3) were included, 
the informed consent for these patients was given by a close relative or guardian. 
 
INCLUSION CRITERIA AND FOLLOW-UP 
Study I 
217 patients with an acute unstable trochanteric fracture (J-M 3 -5)14 or subtrochanteric 
fracture15 treated at Södersjukhuset during the period from October 1998 to January 
2002 were entered in an RCT (Table 1). Patients with pathological fractures and 
patients with rheumatoid arthritis or osteoarthritis were not included. The patients were 
randomised (opaque sealed-envelope technique) to internal fixation with an SGN or an 
MSP. For implant-related reasons, fractures extending more than 5 cm distal to the 
lesser trochanter were excluded. If the MSP was to be used in such fractures, the most 
proximal cortical bone screws would prevent sliding of the plate and, for the SGN, the 
length of the nail (200 mm) was considered to be insufficient. The patients were 
summoned at 4 (mean 4.2) and 12 (mean 13.0) months. At the final follow-up 24 
patients (22%) in the SGN group and 31 (29%) in the MSP group were deceased. Three 
patients (4%) in each group were lost to follow-up. 
 
Study II 
148 patients with an acute stable trochanteric fracture (J-M 1 and 2)14 treated with an 
SHS at any of the 4 university hospitals in Stockholm during the period from January 1 
to December 31, 2003, were included in a prospective cohort study (Table 1). The 
inclusion criteria were absence of severe cognitive dysfunction and independent 
walking capability with or without walking aids before the fracture. Patients with 
pathological fractures were not included. The patients were summoned at 4 (mean 4.9), 
12 (mean 12.9) and 24 (mean 24.8) months. At the final follow-up 43 patients (29%) 
were deceased and 13 (12%) were lost to follow-up. 
 
Study III 
117 patients with an acute unstable trochanteric fracture of the femur (J-M 3 -5)14 
treated with a cephalomedullary nail (TGN) at Södersjukhuset during the period from 
April 2004 to December 2007 were included in a prospective cohort study (Table 1). 
The inclusion criteria were absence of severe cognitive dysfunction and independent 
walking capability with or without walking aids before the fracture. Patients with 
pathological fractures were not included. The patients were summoned at 4 months 
(mean 4.2) and 12 (mean 12.2) months. At the final follow-up 24 patients (21%) were 
deceased and 13 (11%) were lost to follow-up. 
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Study IV 
53 patients with an acute subtrochanteric fracture of the femur15,16 treated with a long 
cephalomedullary nail (LGN) at Södersjukhuset during the period from January 2004 to 
December 2007 were included in a prospective cohort study (Table 1). The inclusion 
criteria were age 60 years or more, absence of severe cognitive dysfunction and 
independent walking capability with or without walking aids before the fracture. 
Patients with pathological fractures were not included. The patients were summoned at 
4 months (mean 4.0) and 12 (mean 12.3) months. At the final follow-up 8 patients 
(15%) were deceased and 6 (13%) were lost to follow-up. 
 
Study V 
The 217 patients from Study I with an acute unstable trochanteric fracture (J-M 3-5)14 
or a subtrochanteric fracture15 were entered in this prospective study focusing on the 
influence of cognitive function on outcome (Table 1). An assessment of cognitive 
function at inclusion was lacking in 4 patients, leaving 213 patients in the study 
group. 
 
Table 1. Patient inclusion algorithm for all studies. 
Study I 
n =  217 
Study II 
n = 148 
Study III 
n = 117 
Study IV 
n = 53 
Study V 
n = 213 
Unstable trochanteric fx and 
subtrochanteric fx 
Stable 
trochanteric fx 
Unstable 
trochanteric fx 
Subtrochanteric 
fx 
Randomised 
SGN 
Randomised 
MSP 
SHS TGN LGN 
The 213 patients 
from Study I with 
data on cognitive 
function according 
to the SPMSQ 
n = 108 n = 109 n = 148 n = 117 n = 53 n = 213 
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METHODS 
 
AGE AND GENDER 
In Studies I and V the mean age was 84 years (65 to 99) and with 81% of the patients 
being women. In Study II the mean age was 83 (68 to 101) years and 74% of the 
patients were females. In Study III the mean age was 84 years (52 to 98) with 74% 
being women. In Study IV the mean age was 82 years (61 to 94) and 77% of the 
patients were females. 
 
FRACTURE CLASSIFICATION 
The patients in all studies had either a trochanteric or a subtrochanteric femoral 
fracture. All radiographs were analysed by two senior consultants (involved in the 
studies and not blinded to the clinical outcome) with extensive experience in the field 
of hip fracture surgery. In case of disagreement between the two, a second opinion 
from a third senior consultant was obtained.  
The trochanteric fractures were classified according to the Jensen-Michaelsen14 
classification system. According to this classification, the undisplaced 2-part fracture 
and the displaced 2-part fracture (J-M 1 and 2) are defined as stable and the 3- and 4-
part fractures with a fracture of the lesser, the greater or both trochanters (J-M 3-5) are 
defined as unstable. The subtrochanteric fractures were classified according to the 
Seinsheimer classification system15 and in Study IV, additionally also according to the 
OTA classification systems.16  
In Studies I and V we included patients with unstable trochanteric and subtrochanteric 
fractures. In Study II only patients with stable trochanteric fractures were included, in 
Study III only patients with unstable trochanteric fractures and in Study IV only patients 
with subtrochanteric fractures.  
 
CO-MORBIDITY 
In Studies I and V co-morbidity  was assessed according to the Ceder classification72 
and graded as A - full health, B - another illness not affecting rehabilitation and C - 
another illness affecting rehabilitation. 
In Studies II, III and IV the patients’ general physical health status was assessed by 
the attending anaesthetist according to the American Society of Anesthesiologists 
(ASA) classification.73 ASA 1 indicates a completely healthy person; ASA 2, a 
person with a mild systemic disease; ASA 3, a person with severe systemic disease 
that is incapacitating; ASA 4, a person with an incapacitating disease that is a 
constant threat to life; ASA 5, a moribund patient who is not expected to live 24 
hours with or without surgery. There were no patients with ASA 5 in any of the 
studies. 
In Studies I and V all patients were examined and cleared by an anaesthetist before 
inclusion. The assessment included a decision as to whether the patient was fit enough 
for both randomisation procedures. 
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RANDOMISATION 
The randomisation procedure in Studies I and V was performed with independently 
prepared, numbered, opaque and sealed envelopes. 
 
COGNITIVE FUNCTION 
Cognitive function was assessed with the Short Portable Mental Status Questionnaire 
(SPMSQ)55 in all studies. This 10-item mental test (Table 2) classifies cognitive 
function into four categories: 8–10 correct answers = cognitive function intact; 6–7 
correct answers = cognitive function mildly impaired; 3–5 correct answers = cognitive 
function moderately impaired; and 0–2 correct answers = cognitive function severely 
impaired. In Studies II, III and IV only patients with absence of severe cognitive 
dysfunction (SPMSQ ≥ 3) were included. 
 
Table 2. SPMSQ. 
1. What is the date today? Right / Wrong 
2. What day of the week is it? Right / Wrong 
3. What is the name of this place? Right / Wrong 
4. What is your telephone number or alt. street address? Right / Wrong 
5. How old are you? Right / Wrong 
6. When were you born? Right / Wrong 
7. Who is the prime minister now? Right / Wrong 
8. Who was the prime minister before him? Right / Wrong 
9. What was your mother’s maiden name? Right / Wrong 
10. Subtract 3 from 20 and keep subtracting 3 from each new number all the way 
down. 
Right / Wrong 
 
ADL 
The activities of daily living (ADL) status was assessed using the Katz index74 in all 
studies. This index is based on an evaluation of the functional independence or 
dependence of patients in bathing, dressing, going to the toilette, transferring, and 
continence and feeding. ADL index A indicates independence in all 6 functions and 
index B independence in all but one of the 6 functions. Indexes C-G indicate 
dependence in bathing and additionally one to 5 more functions. 
 
PREOPERATIVE WALKING ABILITY 
In all studies all patients had independent walking ability with or without walking aids 
before the fracture.  
 
LIVING CONDITIONS 
In all studies the patient’s living condition was categorised as independent (living in 
one’s own home or in housing for the elderly) or as institutionalised (living in a nursing 
home or hospital). 
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TREATMENT MODALITIES 
The patients in Studies I and V were randomly allocated to treatment by either internal 
fixation with an SGN (diameter 11 mm, length 200 mm, valgus bend 10°, neck angle 
125º or 130º; Stryker Howmedica, Sweden) or an MSP (neck angle 135º, 6-hole plate; 
Swemac, Sweden; Figures 10 and 7, respectively). For the SGN, a proximal mini-
invasive incision was performed and followed by reaming of the medullary canal to 13 
mm distally and 17 mm proximally whereupon the nail was introduced. The set screw 
(antirotation screw) and distal locking screw were used in all cases. The MSP was used 
in the biaxial dynamisation mode, which allows sliding along both the femoral neck 
and shaft. In fractures proximal to the entry site of the plate barrel, the entry hole was 
enlarged up to 2.5 cm distally in order to allow axial compression.  
In Study II the SHS used in all cases was a DHS (Synthes, Sweden; Figure 6).  
In Study III fracture fixation was carried out with a TGN (diameter 11 mm, length 180 
mm, valgus bend 4º, neck angle 125º or 130º; Stryker Howmedica, Sweden; Figure 
11). A proximal mini-invasive incision was performed and followed by reaming of the 
medullary canal to 13 mm distally and 17 mm proximally whereupon the nail was 
introduced. The set screw (antirotation screw) and distal locking screw were used in all 
cases.  
In Study IV fracture fixation was carried out with an LGN (Stryker Howmedica, 
Sweden; Figure 13). A proximal mini-invasive incision was made and followed by 
reaming of the medullary canal to 13 mm distally and 17 mm proximally, whereupon 
the nail was introduced. The set screw (antirotation screw) and distal locking screws 
were used in all cases. In cases where acceptable reduction of the fracture was not 
accomplished by closed means, a fracture reduction clamp was introduced to secure 
acceptable reduction during reaming and introduction of the nail.  
In all studies fracture reduction and fixation were carried out with the patient lying 
supine on a fracture table. All surgeons were instructed to insert the nail by hand, never 
to use the hammer and not to use the awl before drilling for the distal locking screw in 
order to minimise the risk of femoral shaft fractures. All patients received trombo-
embolic prophylaxis and perioperative intravenous antibiotics. All patients were 
mobilised with full weight-bearing as tolerated.  
 
PERIOPERATIVE DATA 
The mean operating time, the intraoperative blood loss, the need for blood transfusions 
and the experience of the surgeon were recorded in all studies.  
In Study I the mean operating time was 61 (22 to127) minutes in the SGN group and 65 
(20 to 122) minutes in the MSP group (ns). The intraoperative blood loss was 280 (50 
to 1000) in the SGN group and 400 (25 to 2400) ml in the MSP group (p < 0.01). The 
need for blood transfusions was 860 (0 to 2700) ml in the SGN group and 800 (0 to 
3000) ml in the MSP group (ns). The experience of the surgeons did not differ between 
groups. Approximately 50% of the operations in both groups were performed by 
consultants.  
In Study II the mean duration of surgery was 47 (14 to 105) minutes and the mean 
intraoperative blood loss was 160 (50 to 1000) ml. The surgeon was a certified 
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specialist in orthopaedic surgery (post-registrar or consultant) in 66% of the cases and 
a registrar in the remaining 44%.  
In Study III the mean duration of the surgical procedure was 74 (28 to 210) minutes and 
the mean intraoperative blood loss was 268 (0 to 1200) ml. The surgeon was a certified 
specialist in orthopaedic surgery (post-registrar or consultant) in 48% of the cases and a 
registrar in the remaining 52%.  
In Study IV the mean duration of the surgical procedure was 101 (36 to 260) minutes 
and the mean intraoperative blood loss was 500 (100 to 2000) ml. The surgeon was a 
certified specialist in orthopaedic surgery (post-registrar or consultant) in 55% of the 
cases and a registrar in the remaining 45%. 
 
COMPLICATIONS 
Severe general complications (cardiac, pulmonary, thrombo-embolic or 
cerebrovascular) were recorded in Studies I, III, IV and V.  
Wound infections were recorded in all studies. Deep wound infection was defined as 
an established infection beneath the fascia requiring surgical revision and superficial 
wound infection was defined as a cutaneous/subcutaneous infection requiring 
antibiotic therapy.  
 
RADIOLOGICAL ASSESSMENT 
The fracture reduction and implant position were assessed on the postoperative 
radiographs in Studies I, III, IV and V. The radiographs were analysed by two senior 
consultants (involved in the studies and not blinded to the clinical outcome) with 
extensive experience in the field of hip fracture surgery. In case of disagreement 
between the two, a second opinion from a third senior consultant was obtained. In 
Study II the postoperative fracture reduction and implant position were not assessed. 
The reduction was categorised as good with normal alignment or in slight valgus in 
the AP view, less than 20° of angulation in the lateral view and no more than 4 mm of 
displacement of any fracture fragment. The reduction was considered acceptable if 
two of these criteria were fulfilled, otherwise reduction was considered poor. The 
screw position within the femoral head was defined as described by Kyle75 with the 
femoral head divided into three columns on the AP and lateral views to create 9 
zones. A screw position in the middle third in the lateral view combined with a 
position in the inferior or middle third in the AP view, as well as a posterior position 
in the lateral view combined with a central position in the AP view, was categorised 
as good.76 The minimum screw tip-head circumference distance (corrected for 15% of 
magnification) was measured in the AP and the lateral views.77 
In Studies I, III, IV and V the patients were summoned for a clinical and radiographic 
examination at 4 and 12 months. In Study II the patients were interviewed by phone at 
4, 12 and 24 months and patients reporting problems were scheduled for a follow-up 
visit including a radiographic examination.  
Technical failures were defined as lag-screw penetration, excessive redislocation, e.g. 
medialisation of the femoral shaft, breakage or loosening of the implant, intra- or 
postoperative femoral shaft fracture or non-union of the fracture. Migration of the lag-
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screw within the femoral head or varus angulation of the fracture without lag-screw 
penetration was not regarded as a technical failure. 
The fracture was defined as healed if there were visible trabeculations across the 
fracture line. Non-union was defined as an absence of radiographically visible 
trabeculations across the fracture line, including early displacement or progressive 
displacement. 
 
ASSESSMENT OF CLINICAL OUTCOME 
In the outcome analysis of the RCT (Studies I and V) all patients remained in their 
primary randomisation group regardless of secondary procedures according to the 
intention-to-treat principle. 
In the outcome analysis in all studies, all clinical variables except hip motion were 
assessed by an unbiased observer (a research nurse not involved in the surgery or 
clinical decisions).  
 
HIP FUNCTION 
In all studies hip function was assessed using Charnley´s numerical classification,39 
which defines the clinical state of the affected hip joint in three dimensions: Pain (at the 
hip), Movement (hip motion) and Walking (ability to walk). Each dimension is graded 
from 1 to 6 with 1 = total disability and 6 = normal state (Table 3). 
 
Table 3.  Charnley´s numerical classification. 
 
 
MUSCULOSKELETAL FUNCTION (SMFA) 
In Studies III and IV the musculoskeletal function was assessed using the SMFA. 
SMFA is a 46-item questionnaire40,41 that comprises two parts: the Dysfunction Index 
with 34 items and the Bother Index with 12 items. The Dysfunction Index assesses 
the patients’ perceptions of the amount of difficulty they experience in the 
performance of certain functions (25 items) and how often they encounter difficulties 
when performing certain functions (9 items). The Bother Index asks the patients to 
assess how much they are bothered by problems in different areas of life (e.g. 
 Pain Movement Walking 
1 Severe and spontaneous      0–30° A few metres or bedridden 
2 Severe on attempting to walk, prevents 
all activity 
     60° Time and distance very limited with or 
without walking aids 
3 Tolerable, permitting limited activity      100°  Limited with walking aids, difficult 
without. Able to stand long periods 
4 Only after some activity, disappears 
quickly with rest 
     160° Long distance with walking aids, limited 
without 
5 Slight or intermittent, pain on starting to 
walk but becoming less with normal 
activity 
     210°  No walking aids, walks with a limp 
6 No pain      260°  Normal 
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recreation, work, sleep and rest). These items also have a 5-point response format (1 
point for not bothered at all and 5 points for extremely bothered). The scores of the 
Dysfunction and Bother Indices are calculated by summing up the responses to the 
items and then transforming the scores according to the formula: (actual raw score - 
lowest possible raw score) / (possible range of raw score) x 100. This transformation 
gives the final scores ranging from 0 to100, a higher score indicating poorer function.  
A comparison of the preinjury ratings with the values of a Swedish reference 
population was not possible because there is none available for the SMFA. However, 
the pre-fracture SMFA ratings of our study populations were similar to the normative 
“uninjured” value for the age group > 60 years old in the North American 
population.78,79 
 
HEALTH-RELATED QUALITY OF LIFE (EQ-5D) 
In all studies the HRQoL was rated using the EQ-5D.42 The reliability and validity of 
the EQ-5D has been evaluated in different patient populations and, in a recent review of 
the assessment of the quality of life among older people in which a number of 
instruments were evaluated, it was concluded that there was ‘good evidence’ for the 
validity, reliability and responsiveness of the EQ-5D.80 
The EQ-5D has 5 dimensions: mobility, self-care, usual activities, pain/discomfort and 
anxiety/depression. Each dimension is divided into 3 degrees of severity: no problem, 
some problems and major problems (Table 4).  
 
Table 4.  The EQ-5D self-classifier. 
By placing a tick in one box in each group below, please indicate which statements best 
describe your own health state today. 
Mobility 
I have no problems in walking about 
I have some problems walking about 
I am confined to bed 
 
□ 
□ 
□ 
Self-care 
I have no problems with self-care 
I have some problems washing and dressing myself 
I am unable to wash and dress myself 
 
□ 
□ 
□ 
Usual activities  (e.g. work, study, housework, family or leisure activities) 
I have no problems with performing my usual activities 
I have some problems with performing my usual activities 
I am unable to performing my usual activities 
 
□ 
□ 
□ 
Pain/Discomfort  
I have no pain or discomfort 
I have moderate pain or discomfort 
I have extreme pain or discomfort 
 
□ 
□ 
□ 
Anxiety/Depression 
I am not anxious or depressed 
I am moderately anxious or depressed 
I am extremely anxious and depressed 
 
□ 
□ 
□ 
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Dolan et al.81 used the time trade-off (TTO) method to rate these different states of 
health in a large UK population (UK EQ-5D Index Tariff). We used the preference 
scores (EQ-5D index scores) generated from this population when calculating the scores 
for our study population. A value of 0 indicated the worst possible state of health and a 
value of 1 indicated full health. This is a divergence from the UK EQ-5D Index Tariff 
where some health states were given negative scores. But the appropriate scaling of 
negative scores is questioned82 and the same approach was used when generating the 
values for an age-matched Swedish population.83 
All studies included an assessment of the patients’ HRQoL the week before the fracture 
(recall). To validate the method of rating the prefracture HRQoL and to analyse recall 
bias, the EQ-5D index scores prior the fracture were compared with those of the age-
matched Swedish reference population (Table 5).83 Regarding recall bias, a recent 
study reports that older patients can accurately recall their previous health status up to 6 
weeks.84  
In Study V the information was collected from a proxy for patients with severe 
cognitive dysfunction (SPMSQ<3). A close relative or caregiver was asked to rate how 
he or she thinks the patient would rate his or her health if he or she were able to 
communicate. This approach has also been used previously for the EQ-5D in patients 
with cognitive dysfunction and dementia.85-87  
 
Table 5. EQ-5D index scores for the relevant age groups of the age-matched Swedish 
reference population. 
EQ-5Dindex scores 
Age (years) 60–69 70–9 80–88 
Total 0.80 0.79 0.74 
   Male 0.83 0.81 0.74 
   Female 0.78 0.78 0.74 
 
 
In Study I (mean age 84 years, 81% being female) the prefracture EQ-5D index score was 
0,64 in patients without severe cognitive dysfunction (SPMSQ ≥3).  
In Study II (mean age 83 years, 74% being female) the prefracture EQ-5D index score 
was 0, 69. 
In Study III (mean age 84 years, 74% being female) the prefracture EQ-5D index score 
was 0.79. 
In Study IV (mean age 82 years, 77% being female) the prefracture EQ-5D index score 
was 0.85. 
In Study V in the subgroup of 50 patients with SPMSQ < 3 (mean age 86 years, 78% 
being female) the prefracture EQ-5D index score was 0.24. In the subgroup of 163 
patients with a SPMSQ ≥ 3 (mean age 83 years and 82% being female) the prefracture 
EQ-5D index score was 0.64.  
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STATISTICAL METHODS 
In Study I the statistical software used was SPSS 11.5 for Windows. The Mann-
Whitney U-test was used for scale variables and ordinal variables in independent 
groups. Nominal variables were tested using the Chi-square test or Fisher’s exact test. 
A Wilcoxon signed ranks test was used to compare scores between baseline and follow-
up. A correlation analysis was performed using Spearman's rho test. All tests were two-
sided. The results were considered significant at p < 0.05. Trend values, 0.05 ≥ p < 0.1, 
are displayed; all other values are reported as not significant (ns). 
In Study II the statistical software used was SPSS 15.0 for Windows. The Wilcoxon 
signed-ranks test was used when comparing EQ-5D data. The tests were two-sided. 
The results were considered significant at p < 0.05.  
In Study III the statistical software used was SPSS 18.0 for Windows. Nominal 
variables were tested using the Chi-square test or Fisher’s exact test. The Wilcoxon 
signed-ranks test was used when comparing EQ-5D data. The tests were two-sided and 
the results were considered significant at p < 0.05.  
In Study IV the statistical software used was SPSS 17.0 for Windows. Nominal 
variables were tested using the Chi-square test or Fisher’s exact test. The Wilcoxon 
signed-ranks test was used when comparing EQ-5D data. The tests were two-sided and 
the results were considered significant at p < 0.05.  
In Study V the statistical software used was SPSS 13.0 for Windows. The Mann-
Whitney U-test was used for scale variables and ordinal variables in independent 
groups. Nominal variables were tested using the Chi-square test or Fisher’s exact test. 
A Wilcoxon signed ranks test was used to compare scores between baseline and follow-
up. All tests were two-sided. A Cox regression analysis was performed in order to 
evaluate factors of importance for mortality. The results were considered significant at 
p < 0.05. All other values are reported as not significant (ns).  
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RESULTS 
STUDY I 
Baseline data 
Baseline data for all patients included (n = 217) are displayed in Table 6. There were 
no significant differences between the SGN and MSP groups regarding baseline data or 
fracture type. There was a trend towards slightly older patients in the SGN group, 84.6 
years in the SGN group compared to 82.7 years in the MSP group (p = 0.058).  
 
Table 6. Baseline data for all included patients (n = 217) 
 SGN (n = 109) MSP (n = 108) 
Mean age in years 84.6 82.7 
Mean cognitive function (SPMSQ) 5.7 5.8 
Mean EQ-5D index score  prefracture*  0.66 0.63 
Gender, female, n (%) 92 (84) 84 (78) 
Mobility, no walking aid or just one stick, n (%) 67 (62) 71 (66) 
ADL A&B, n (%) 82 (75) 72 (67) 
Co-morbidity Ceder A&B, n (%) 45 (41) 48 (44) 
From independent living, n (%) 92 (84) 95 (88) 
* Only patients with SPMSQ ≥ 3 
 
Surgical outcome 
Six patients in the SGN group were operated on using a method at variance with the 
randomisation. Three of these patients sustained an intraoperative femoral fracture. 
Two of them were caused by an inadequate surgical technique. In spite of the 
recommended operative technique, a hammer was used during insertion of the nail in 
one case and a wrong entry point was used in another, leading to excessive force during 
insertion of the nail. The intraoperative fractures were all recognised during the primary 
procedure and the SGN was replaced in all cases with an LGN with uneventful 
outcomes. In two patients an LGN was used owing to misinterpretation of the study 
protocol by the surgeons. Finally, in one case the surgeon considered open reduction 
necessary and therefore changed intraoperatively to an MSP. 
The reduction and screw position were assessed after the termination of the study and 
the primary postoperative radiographs were retrieved in 195 patients. In the SGN 
group, the reduction was considered good in 63% of the patients as compared to 40% in 
the MSP group (p < 0.005). In 6 out of 9 patients undergoing reoperation owing to 
technical failures (the primary postoperative radiographs were not retrievable in one 
case), the reduction was not considered good (p = 0.074). The screw position was 
considered good in 87% in the SGN group and 93% in the MSP group (ns). There was 
a trend towards more frequent reoperations owing to technical failures among patients 
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with an unacceptable screw position (p = 0.094). The mean minimum screw tip-head 
circumference distance was 6 (1–14) mm in the SGN group and 7 (1–18) mm in the 
MSP group (p = 0.099). There was no correlation between this difference in distance 
and the need for reoperation owing to technical failure. 
Severe general complications, including deaths, before the 4-month follow-up were 
more frequent in the MSP group (p < 0.05). The mortality rate in the SGN group was 
10% and 3% of the patients had another severe complication (cardiac, pulmonary, 
thrombo-embolic or cerebrovascular) compared to 20% and 4%, respectively, in the 
MSP group. 
The number of technical failures did not differ between groups as shown in Table 7.  
 
Table 7. Technical failures with reference to fracture type.  
SGN (n = 109) MSP (n = 108)  
n  (%) n (%) 
Trochanteric fractures ( n= 189)  93 (85.3) 96  (88.9) 
   No complication 87  (93.5) 91  (94.8) 
   Lag-screw penetration 3  (3.2) 4  (4.2) 
   Redisplacement/medialisation 0  (0) 1  (1.0) 
   Intraoperative femoral fracture 3  (3.2) 0 (0) 
Subtrochanteric fractures (n = 28)  16 (14.7) 12 (11.0) 
   No complication 16  (100) 10  (83.3) 
   Lag-screw penetration 0  (0) 0  (0) 
   Redisplacement/medialisation 0  (0) 2  (16.7) 
   Intraoperative femoral fracture 0  (0) 0 (0) 
 
The three patients in the MSP group with redisplacement/medialisation had 
radiographically excessive medialisation of the femoral shaft and severe pain at the hip, 
making further ambulation impossible. One of the patients in the MSP group with a 
minor lag-screw penetration declined further surgery. Another patient in the MSP 
group (case no. 91) (Table 8) with a radiographically healed fracture had the implant 
removed after 10 months owing to local pain. After a few weeks a stress fracture in the 
femoral neck was diagnosed and the patient underwent reoperation with a total hip 
replacement (THR) with an uneventful outcome. This case was not included among 
technical failures in the MSP group. 
There was a trend towards more frequent reoperations in the MSP group (Table 8). The 
total number of reoperated patients was 3 out of 109 (2.8%) in the SGN group and 9 
out of 108 (8.3%) in the MSP group (p = 0.072). The reoperation rate for unstable 
trochanteric fractures was 3 out of 93 (3.2%) in the SGN group and 6 out of 96 (6.3%) 
in the MSP group (ns). Regarding subtrochanteric fractures, there were no reoperations 
in the SGN group (n = 16) as compared to 3 in the MSP group (n = 12) (p = 0.067). 
Fracture healing was demonstrated radiographically at the final follow-up in 136 out of 
146 available patients and clinically in the rest. There were no postoperative femoral 
shaft fractures in any of the groups during the 12-month follow-up.   
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Table 8. All reoperated patients (n = 12). 
Randomisation Indication Reoperation Time Fx type 
No. 43 MSP Deep infection Multiple revisions,  
Healed fx at 12 months 
1.6 months S5 
No. 59 SGN L-S penetration THR   3.6 months J-M 3 
No. 68 MSP L-S penetration Girdlestone arthroplasty 
Lost at 12-month f-u 
3.4 months J-M 4 
No. 91 MSP 1/ Local pain 
2/ Stress fx in the 
     femoral neck 
1/ Extraction of MSP 
2/ THR 
1/ 10.3 months 
2/ 10.9 months 
J-M 5 
No. 96 MSP L-S penetration THR  5.8 months J-M 5 
No. 104 SGN L-S penetration THR  4.4 months J-M 5 
No. 139 MSP L-S penetration THR 1.3 months J-M 4 
No. 152 SGN L-S penetration THR  12.1 months J-M 5 
No. 159 MSP Redisplacement, 
medialisation 
1/ DCS 
2/ THR  
1/ 1.0 months 
2/ 7.4 months 
S2C 
No. 161 MSP Redisplacement, 
medialisation 
LGN 0.4 months S2C 
No. 169 MSP Redisplacement, 
medialisation 
PFN 0.5 months J-M 5 
No. 219 MSP Deep infection Girdlestone arthroplasty 
Deceased after 2.8 months 
1.0 months J-M 5 
Time = time elapsed from the primary operation; DCS = dynamic compression screw; PFN = proximal 
femoral nail; L-S penetration = lag-screw penetration. 
 
There was a trend towards more frequent postoperative infections in the MSP group 
(p=0.05). There were 6 superficial wound infections in the MSP group as compared to 
two in the SGN group. Furthermore, there were two deep wound infections in the MSP 
group, one leading to a Girdlestone arthroplasty and the subsequent death (case no. 
219) of a 94-year-old woman and one leading to multiple revisions but finally a healed 
fracture in a 91-year-old woman (case no. 43) (Table 8).  
 
Functional outcome and HRQoL 
There were no significant differences in ADL between the groups at any of the follow-
ups. At 4 months, 49% in the SGN group and 60% in the MSP group were categorised 
as indexes A & B; at 12 months, the figures were 57% and 63%, respectively. Hip 
function (Table 9) and the HRQoL according to the EQ- 5D (Figure 17) did not differ 
between the groups at any of the follow-ups. The reduction in HRQoL (EQ-5D index 
score) between prefracture and both follow-ups was highly significant in both groups (p 
< 0.005). 
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Table 9. Hip function according to the Charnley score for all patients available at each 
follow-up. No significant differences between randomisation groups on any occasion. 
SGN MSP  
Mean Mean 
Pain               4 months (n = 163) 
                     12 months (n = 155)            
4.8 
5.3 
4.7 
5.2 
Movement     4 months (n =153) 
                     12 months (n = 152) 
4.9 
4.9 
4.7 
4.8 
Walking         4 months (n = 165) 
                     12 months (n = 155) 
2.5 
2.8 
2.6 
2.9 
 
 
Figure 17. HRQoL for all patients without severe cognitive dysfunction (SPMSQ ≥ 3) 
before fracture and available at each follow-up. (n = 162 at inclusion, n = 142 at 4 
months and n = 134 at 12 months). No significant differences between randomisation 
groups on any occasion. 
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STUDY II 
Baseline data 
Baseline data for all patients included (n=148) are displayed in Table 10.  
 
Table 10. Baseline data for all patients included (n = 148). 
 
Mean age in years  83.2, range 68 to 101 
Gender, female, n (%) 109 (74) 
Mean cognitive function (SPMSQ) 7.6, range 3–10 
Mean EQ-5D index score  prefracture 0.69, range 0.0–1.0 
Walking aids, n (%)       None 
                                         Stick or crutches 
                                         Walking frame 
60 (41) 
33 (22) 
55 (37) 
ADL A and B, n (%) 129 (89)* 
From independent living, n (%)  134 (91) 
ASA , n (%)                   1 
                                        2 
                                        3 
                                        4 
5 (3) 
68 (46) 
72 (49) 
 3 (2) 
* 3 missing values 
 
Surgical outcome  
In total during the two- year follow-up period, 4 patients (3%) were reoperated upon. 
All reoperations were performed within 6 months and in three of them the indication 
was lag-screw penetration due to varus collapse of the fracture (Table 11). The lag-
screw position after the index operation in two of the patients reoperated upon was 
unsatisfactory with a cranial (AP view) and dorsal (lateral view) position.  
 
Table 11.Data on the 4 patients reoperated upon. 
Indication Reoperation/reoperations Time (months) 
L-S penetration 1/ HA 
2/ First dislocation – closed reduction  
3/ Second dislocation – Girdlestone arthroplasty 
1.3 
1.5 
1.5 
Redisplacement Reosteosynthesis 2.1 
L-S penetration THR   3.0 
L-S penetration THR 5. 3 
Time = time elapsed from the primary operation; L-S penetration = lag-screw penetration. 
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There were no deep infections. Five patients (3%) had superficial infections requiring 
antibiotic therapy.  
 
Functional outcome and HRQoL 
Pain at the hip, walking ability and ADL function for all patients available at each 
follow-up is displayed in Table 12. At the final follow-up 81% of the patients reported 
no or only slight or intermittent pain at the hip (Charnley score 5-6). 55% had regained 
their prefracture walking ability, 66% had the same level of ADL function and 89% of 
the patients who were living independently before the fracture were still living 
independently after 24 months.   
 
Table 12. Pain at the hip, walking ability and ADL function for all patients available at 
each follow-up (4 months, n=124; 12 months, n=112; 24 months, n=92). 
Pain, mean Charnley score                                                                4 months 
                                                                                                            12 months  
                                                                                                            24 months  
5.15 
5.38 
5.44 
Pain, Charnley score 5 or 6, n (%)                                                    4 months 
                                                                                                            12 months  
                                                                                                            24 months  
86 (72)5 
80 (77)8 
71 (81)4 
At least similar walking ability as prefracture, n (%)                    4 months 
                                                                                                            12 months 
                                                                                                            24 months                   
58 (46) 
58 (52)1 
50 (55)1 
At least similar level of ADL function as prefracture, n (%)         4 months 
                                                                                                            12 months 
                                                                                                            24 months 
74 (62)5 
67 (63)5 
59 (66)3 
Still independent living, n (%)*                                                         4 months 
                                                                                                            12 months 
                                                                                                            24 months 
103(89)1 
87(85)5 
76 (89)2 
The figures in superscript refer to the number of missing values on each follow-up occasion.  
* The calculation is based on the number of patients available at each follow-up who were living 
independently before the fracture. 
 
The EQ-5D index score decreased from 0.69 before the fracture to 0.57 at 4 months (p 
< 0.001) and 0.59 at 12 months (p < 0.05). At 24 months the EQ-5D index score, 0.66, 
did not differ from the prefracture level (p = 0.522) (Figure 18). 
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Figure 18. The EQ-5D index score for all patients available at each follow-up. At 
inclusion n = 148; 4 months, n = 124; 12 months, n = 112; 24 months, n = 92.  
 
 
 
The figures in superscript refer to the number of missing values on each follow-up 
occasion.  
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STUDY III 
Baseline data 
Baseline data for all patients included (n = 117) are displayed in Table 13.  
 
Table 13. Baseline data for all patients included (n = 117). 
Mean age in years                                  84.1, range 52 to 98 
Gender, female (%) 86 (74) 
ASA, classification (%)  1 
                                          2 
                                          3 
                                          4 
5 (4)  
51 (44) 
48 (41) 
13 (11) 
Mean cognitive function (SPMSQ)                                 8.6, range 4 to 10 
From independent living (%)  116 (99) 
ADL A and B (%) 111 (95) 
Walking aids (%)        None 
                                      Stick or crutches 
                                      Walking frame 
53 (45) 
27 (23) 
37 (32) 
Mean SMFA*     Dysfunction Index prefracture 
                              Bother Index prefracture 
24.8,  range 0.0 to 89.7 
14.3,  range 0.0 to 91.7 
Mean EQ-5D index score  prefracture  0.79,  range 0.0 to 1.0 
Fracture type (%)           JM3 
                                          JM4 
                                          JM5 
33 (28) 
21 (18) 
63 (54) 
* 4 missing values. 
 
Surgical outcome 
Two out of 33 (6.1%) patients with a J-M type 3 fracture, 1 out of 21 (4.8%) patients 
with a J-M type 4 fracture and 11 out of 63 patients (17.5%) with a J-M type 5 
fracture were reoperated upon (p = 0.14). A comparison based instead on the number 
of fracture fragments, i.e. 3 fragments (J-M types 3 and 4) vs. 4 fragments (J-M type 
5) demonstrated a significantly lower reoperation rate after a 3-part fracture, i.e. 3 out 
of 54 (5.6 %), compared to after a 4 part fracture, i.e. 11 out of 63 (17.5 %) (p =  
0.048).   
Overall, independently of fracture type, the radiological reduction was considered 
good in 70 fractures (60%), acceptable in 39 (33%) and poor in the remaining 8 (7%) 
fractures. The corresponding values in the J-M 5 group (n = 63) were 29 (46%), 28 
(44%) and 6 (10%). Good reduction was accomplished more often in the J-M type 3 
and 4 fractures, in 25 out of 33 (76%) and 16 out of 21 (76%), respectively. There 
was a trend towards more frequent reoperations in patients with poorly reduced 
fractures: in 3 out of 8 (38%), compared to 11 out of 109 (10%) in patients with 
acceptable or good reduction (p = 0.054).  
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The screw position was considered good in 113 of the 117 patients (97%). There was 
no correlation between the screw position and the number of reoperations. The 
overall minimum screw tip-head circumference distance was a mean of 7.6 (-1 to 20) 
mm. The distance did not differ significantly between patients who were reoperated 
upon compared to those who were not: mean 6.4 mm compared to 7.8 mm.  
14 patients (12.0%) were reoperated upon due to technical failures (Table 14). All 
reoperations but one were due to secondary lag-screw penetration and cut-out. In one 
patient (No. 101) the lag screw was replaced with a shorter one early on after the 
index operation due to lag-screw penetration seen on the first postoperative X-ray. 
One additional patient (No. 69) was also reoperated upon with replacement with a 
shorter lag screw after approximately one month. The remaining 12 patients received 
a hip replacement: in 10 patients a total hip replacement (THR) and in two a bipolar 
hemiarthroplasty (HA). The rationale for choosing HA in patients with a lag-screw 
penetration may be questioned since most often the penetrating screw has caused 
significant erosion in the acetabulum.  In one of our patients (No. 112) the reason was 
that there was no obvious acetabular lesion. In the other patient (No. 11), the lesion in 
the acetabulum was considered intraoperatively to be negligible, and not affecting the 
outcome of the HA. This assessment in conjunction with the patient’s age, 95, was 
the reason why the surgeon opted to use an HA. All reoperations were performed 
within the first 6 months after the index procedure.  
No patient sustained a postoperative fracture of the femoral shaft distal to the nail 
during the 12-month follow-up period and no intraoperative femoral fractures were 
discovered. 
 
Table 14. Data on all patients reoperated upon, including indication, type of operation 
and time from index surgery (n = 14). 
Patient 
No. 
Fx type Indication Reoperation/s Time, months 
No. 101 JM 4 L-S penetration  Change of L-S  0.3 
No. 112 JM 5 L-S penetration/cut-out Bipolar HA 0.5 
No. 111 JM 5 L-S penetration/cut-out THR 0.6 
No. 69 JM 5 L-S penetration/cut-out Change of L-S 1.1 
No. 21 
No. 95 
JM 5 
JM 5 
L-S penetration/cut-out 
L-S penetration/cut-out 
THR 
THR 
1.4 
1.7 
No. 34 JM 5 L-S penetration/cut-out THR 2.0 
No. 114 JM 5 L-S penetration/cut-out THR 2.4 
No. 11 JM 3 L-S penetration/cut-out Bipolar HA 2.6 
No. 83 JM 5 L-S penetration/cut-out THR 2.7 
No. 107 JM 5 L-S penetration/cut-out  THR 3.1 
No. 84 JM 5 L-S penetration/cut-out THR 5.4 
No. 20 JM 5 L-S penetration/cut-out THR 5.4 
No. 36 JM 3 L-S penetration/cut-out THR 5.8 
Time = time elapsed from the primary operation; L-S = lag-screw 
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Functional outcome and HRQoL for all patients 
Hip function according to the Charnley hip score and general musculoskeletal function 
according to the SMFA for all patients available at each follow-up are displayed in 
Table 15. The SMFA Dysfunction Index increased from 24.8 before the fracture to 
43.8 and the value at 12 months was 42.4. The SMFA Bother Index increased from 
14.3 before the fracture to 36.2 at 4 months and 33.7 at 12 months. The deterioration on 
both follow-up occasions compared to before fracture was highly significant for both 
indices (p < 0.001 in all 4 comparisons). There were no significant differences in 
outcome regarding neither the Charnley hip score nor the SMFA on comparing the 
different fracture types (data not shown).  
 
Table 15. Hip function according to the Charnley score and musculoskeletal function 
according to the SMFA for all patients available at each follow-up (n = 103 at 4 months 
and n = 80 at 12 months).  
4 months 12 months  
Mean Mean 
Charnley score pain 4.61 4.8 
                           movement 5.26 5.41 
                           walking 3.01 3.4 
SMFA Dysfunction Index 43.85 42.42 
             Bother Index 36.25 33.72 
The figures in superscript refer to the number of missing values. 
 
The EQ-5D index score decreased from 0.79 before the fracture to 0.49 at 4 months (p 
< 0.001) and remained at almost the same level at 12 months: 0.51 (p < 0.001 for both 
follow-ups compared to before fracture) (Figure 19).  
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Figure 19. The EQ-5D index score for all patients before fracture and available at each 
follow-up (n = 117 at inclusion, n = 103 at 4 months and n = 80 at 12 months). 
 
There were no significant differences in outcome regarding the EQ-5D index score on 
comparing the different fracture types (data not shown). 
At the final follow-up 88% of the patients (70/80) were still categorised as indexes A or 
B and 93% (74/80) were still living independently.   
 
Outcome for patients reoperated upon with a THR 
Since a THR is the most common and the most appropriate reoperation in the majority 
of patients with trochanteric fractures suffering from a secondary lag-screw 
penetration/cut-out, it could be of interest to analyse the outcome for these patients 
separately. The SMFA Dysfunction Index increased from 23.5 before the fracture to 
51.3 at 4 months and the value at 12 months was 43.4. The corresponding values for the 
SMFA Bother Index were 12.3, 39.8 and 36.6, respectively. The EQ-5D index score 
decreased from 0.82 before the fracture to 0.33 at 4 months and 0.58 at 12 months. 
 
  44 
STUDY IV 
Baseline data 
Baseline data for all patients included (n = 53) are displayed in Table 16.  
 
Table 16. Baseline data for all patients included (n = 53). 
Mean age in years                                  82.3, range 61–94 
Gender, female (%) 41 (77) 
ASA classification (%)   1 
                                          2 
                                          3 
                                          4 
3 (6) 
22 (41) 
27 (51) 
1 (2) 
Mean cognitive function (SPMSQ)                   8.9 (1.4), range 3–10 
From independent living  (%)  55 (100) 
ADL A and B (%) 52 (98) 
Walking aids (%)        None 
                                      Stick or crutches 
                                      Walking frame 
30 (57) 
13 (24) 
10 (19) 
Mean SMFA* (SD)     Dysfunction Index 
                                      Bother Index 
17.9 (9.2), range 0–40 
9.7 (12.1), range 0–52 
Mean (SD) EQ-5D index score  prefracture  0.85 (0.16), range 0.23–1.0 
Fracture type (%)          S2A 
                                          S2B 
                                          S2C 
                                          S3A 
                                          S3B 
                                          S5 
2 (4) 
4 (8) 
11 (21) 
15 (28) 
1 (2) 
20 (38) 
* One missing value 
 
Surgical outcome  
There was no significant correlation between fracture type and the need for revision 
surgery. The reduction was considered good in 26 patients (50%) and acceptable in 
the remaining 26 (50%). None of those with good reduction were reoperated upon, 
while 6 (23%) of those with acceptable reduction had reoperations (p < 0.05).  
In total six patients (11%) were reoperated upon, five were due to technical failures 
and one resulted from an ipsilateral distal femur fracture (Table 17). Of the technical 
failures, three were due to lag-screw penetration and a non-union developed in two. 
The patient sustaining a distal shaft fracture was treated with plate fixation. The lag-
screw position was considered good in 48 (92%) of the 52 patients. We found no 
significant correlation between reoperations and lag-screw position. The mean 
minimum lag-screw tip-head circumference distance was 7 (SD 3, range 1–14) mm 
and patients reoperated upon had a significantly increased distance, 10 (SD 3) mm 
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compared to 6 (SD 3) mm in those not reoperated upon (p < 0.005). There were no 
deep infections. 
 
Table 17. Data on all patients reoperated upon including indication, type of operation 
and time from index surgery (n = 6). 
Patient 
No.  
Fx type Indication for reoperation Type of reoperation Time, 
months 
No. 9 S2B L-S penetration THR 1.1 
No. 34 S2C Fx close to tip of the nail  LCP 2.0 
No. 24 S2C L-S penetration THR 4.1 
No. 38 S5 Non-union THR 9.1 
No. 45 S5 1/ Delayed union 
2/ Non-union 
Dynamisation 
DCS 
10.3 
13.8 
No. 28 S5 Minimal L-S penetration, healed fx Extraction of LGN 16.0 
Time = time elapsed from the primary operation; L-S = lag-screw; LCP = Locking compression plate. 
 
Functional outcome and HRQoL 
Hip function results according to the Charnley hip score and general musculoskeletal 
function according to the SMFA for all patients available at each follow-up are shown 
in Table 18. The SMFA Dysfunction Index increased from 18 before the fracture to 46 
at 4 months and to 43 at 12 months. The SMFA Bother Index increased from 10 before 
the fracture to 43 at 4 months and 40 at 12 months. The deterioration at both follow-ups 
compared to pre-fracture was highly significant for both indices (p < 0.001 in all 4 
comparisons). 
 
Table 18. Hip function according to the Charnley score and musculoskeletal function 
according to the SMFA for all patients available at each follow-up (n = 46 at 4 months 
and n = 39 at 12 months).  
4 months 12 months  
Mean Mean 
Charnley, score pain 4.51 4.7 
                          movement 4.92 5.12 
                          walking 3.01 3.7 
SMFA Dysfunction Index 45.91 43.21 
             Bother Index 42.61 39.81 
The figures in superscript refer to the number of missing values. 
 
The EQ-5D index score decreased from 0.85 before the fracture to 0.49 at 4 months (p < 
0.001) and remained at almost the same level at 12 months, 0.52 (p < 0.001; p values 
are given for the difference between follow-ups and before fracture) (Figure 20).  
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Figure 20. The EQ-5D index score for all patients before fracture and available at each 
follow-up (n = 53 at inclusion, n = 46 at 4 months and n = 39 at 12 months).  
 
* One missing value at 4 and 12 months, respectively. 
 
 
At the final follow-up, 90% of the patients (37/41) were still categorised by index A or 
B in ADL status and 98% (40/41) were still living independently.   
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STUDY V 
Baseline data 
The baseline data for all patients included (n = 213) are shown in Table 19. Compared 
to patients with SPMSQ ≥ 3, patients with SPMSQ < 3 were older, were more often 
admitted from an institution and had a lower HRQoL, an increased need for walking 
aids and more impaired walking ability and were more dependent in ADL before the 
fracture. The surgical interventions, SGN or MSP, were evenly distributed between the 
two groups (data not shown). 
 
Table 19. Baseline data for all patients included (n=213) with regard to cognitive 
function according to the SPMSQ. 
 SPMSQ <  3 
n = 50 
SPMSQ ≥ 3 
N = 163 
 
p 
Mean age in years 86.1 82.8 < 0.005 
Mean EQ-5D index score  prefracture* 0.24 0.64 < 0.001 
Hip function, mean score walking  3.0 4.0 < 0.001 
Gender (female),  n (%) 39 (78) 133 (82) ns 
Walking aid, none or just one stick, n (%)  21 (42) 114 (70) < 0.001 
ADL A & B, n (%)   10 (20) 141 (87) < 0.001 
Independent living, n (%)   26 (52) 157 (96) < 0.001 
Co-morbidity Ceder C, n (%) 50 (100) 76 (47) < 0.001 
* 1 missing value 
 
Surgical outcome  
The postoperative infection or reoperation rate did not differ between the groups. In 
the SPMSQ < 3 group, there were two superficial infections (4.0%) and, in the 
SPMSQ ≥ 3 group, there were 6 superficial and two deep infections (4.9%). The total 
number of reoperations in the SPMSQ < 3 group was 2 out of 50 (4.0%) compared to 
10 out of 163 (6.1%) in the SPMSQ ≥ 3 group. 
 
Mortality  
General complications besides mortality did not differ between the groups.  The one-
year mortality rate was 24 out of 50 (48%) in patients with SPMSQ < 3 and 29 out of 
163 (18%) in patients with SPMSQ ≥ 3 (p < 0.001). The mortality rate for men was 20 
out of 41 (49%) and 33 out of 172 (19%) for women (p < 0.001). The mortality rate 
was 10 out of 58 (17%) in patients ≤ 80 years of age and 43 out of 155 (28%) in 
patients > 80 years of age (ns).  
We performed a Cox regression analysis in order to further evaluate factors of 
importance for mortality during the first 12 months. Cognitive function according to the 
SPMSQ, age and gender were tested as independent variables in the model. The 
analysis showed that an SPMSQ score < 3 and male gender were associated with 
increased mortality during the first 12 months (Table 20).  
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Table 20. The estimated hazard ratio (HR) and 95% confidence interval (CI) for 
patients deceased at the 12-months follow-up in relation to cognitive function, age 
and gender (Cox regression). 
Deceased before the 12-month follow-up  
HR 95% CI p 
SPMSQ  ≥ 3 
                < 3 
1 (reference) 
3.4 
 
1.9-6.1 
 
<0.001 
Age         ≤  80 years 
                >  80 years 
1 (reference) 
1.5 
 
0.7-3.1 
 
ns 
Gender,   female    
                male 
1 (reference) 
3.9 
 
2.2-6.9 
 
<0.001 
 
The estimated cumulated survival in relation to cognitive function adjusted for age and 
gender (Cox regression) is displayed in Figure 21 and the corresponding survival curve 
for the estimated cumulated survival in relation to gender adjusted for cognitive 
function and age (Cox regression) is shown in Figure 22. 
 
Figure 21. The estimated cumulated survival in relation to cognitive function 
adjusted for age and gender (Cox regression); SPMSQ < 3 (n = 50) and SPMSQ ≥ 3 
(n = 163). 
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Figure 22. The estimated cumulated survival in relation to gender adjusted for 
cognitive function and age (Cox regression); female (n = 172) and male ≥ 3 (n = 41). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Functional outcome and HRQoL 
The results regarding hip function, i.e. walking ability and pain, are displayed in Table 
21. Patients with SPMSQ < 3 had a significantly more impaired walking ability on all 
occasions compared to patients with SPMSQ ≥ 3. Furthermore, they showed a 
significant deterioration in walking ability with 36% of the patients wheel-chair-bound 
or bedridden at the final follow-up. This contrasted with the pain assessment, which 
was similar in both groups.  
 
Table 21. Hip function according to the Charnley score for all patients before the 
fracture (n = 213) and for all patients available at each follow-up (n = 164 at 4 
months; n = 154 at 12 months). Mean values and percentages of patients with the 
score 1 (worst possible) are displayed.  
SPMSQ < 3 SPMSQ ≥ 3   
Mean Score 1 Mean Score 1 p 
Walking       Before fracture 
                      At 4 months 
                      At 12 months* 
3.0 
1.8 
1.9 
0% 
32% 
36% 
4.0 
2.7 
3.0 
0% 
11% 
9% 
<0.001 
<0.001 
<0.001 
Pain              At 4 months** 
                      At 12 months*                   
4.9 
5.5 
3% 
0% 
4.7 
5.2 
1% 
1% 
ns 
ns 
* 1 missing value; **2 missing values 
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As could be expected, patients with SPMSQ < 3 were more dependent in ADL function 
on all occasions (Table 22).  
 
Table 22. ADL status among randomisation groups according to Katz for all patients 
before the fracture (n = 213) and for all patients available at each follow-up (n = 164 at 
4 months; n = 154 at 12 months). Mean values and percentages of patients with the 
score 6 (worst possible) are displayed. 
SPMSQ < 3 SPMSQ ≥ 3   
Mean Score 6 Mean Score 6 p 
ADL      Before fracture  
              At 4 months 
              At 12 months           
3.2 
4.7 
4.3 
24% 
29% 
39% 
0.5 
1.6 
1.5 
0% 
7% 
5% 
<0.001 
<0.001 
<0.001 
 
Moreover, they also showed a significant deterioration with 39% being totally 
dependent in all functions at the final follow-up. This inability to manage activities of 
daily living is mirrored in the high percentage of patients with SPMSQ < 3 who were 
institutionalised at the time of the 12-month follow-up: 16 out of 23 patients (69%) 
compared to 14 out of 131 (11%) for patients with SPMSQ ≥ 3 (p < 0.001).  
Patients with SPMSQ < 3 had a significantly lower EQ-5D index score at inclusion and 
on each follow-up occasion and also showed a continuous deterioration in HRQoL in 
contrast to patients with SPMSQ ≥ 3, who had significant improvement in the EQ-5D 
index score between the 4- and 12-month follow-ups ( p < 0.05) (Figure 23). 
 
Figure 23. The EQ-5D index score for patients with (SPMSQ < 3) and without (SPMSQ 
≥ 3) severe cognitive dysfunction, including all patients before the fracture (n = 213) 
and for all patients available at each follow-up (n = 164 at 4 months; n = 154 at 12 
months).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 * 1 missing value; ** 2 missing values 
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GENERAL DISCUSSION 
The overall aim of the thesis was to evaluate the outcome in patients with stable 
trochanteric (Study II), unstable trochanteric (Studies I and III) and subtrochanteric 
(Studies I and IV) femoral fractures with aspects of surgical methods, including an 
assessment of functional outcome and HRQoL. Moreover, the aim was to evaluate 
whether severe cognitive dysfunction, assessed with a validated instrument, the 
SPMSQ, could predict the outcome regarding function, HRQoL and mortality (Study 
V). 
 
FAILURE RATES AND REOPERATION RATES 
2-part fractures  
The results of Study II confirmed the good surgical outcome and low reoperation rate 
after a stable trochanteric fracture (J-M 1 -2)14 treated with an SHS. Our finding of a 
3% reoperation rate was in conformity with previous studies.88,89 The reoperation 
rate, presented separately for stable trochanteric fractures treated with 
cephalomedullary nails, are difficult to find in the literature since most studies include 
a mixed population of stable and unstable fractures. However, equally good results 
after a stable trochanteric fracture have been reported by Leung et al.90 with the 
prototype for the TGN and by Zou and co-workers for the PFNA.91 The MSP with its 
potential for compression along the femoral shaft has, theoretically, no major 
advantages compared to the SHS in patients with stable trochanteric fractures. 
However, the MSP has also been used in this fracture type and showed good results.92 
 
3- and 4-part fractures 
The findings of Study I show generally good results with both the SGN and MSP in 
patients with unstable trochanteric fractures with technical failure rates of 6% 
(including 3% intraoperative femoral fractures) and 5%, respectively. Furthermore, 
there was a trend towards a decreased number of reoperations in the SGN group: 3%, 
compared to the MSP group, 6%.  
The results with the SGN in Study I compared favourably with those of previous 
reports on the SHS88,89,93-96 and were comparable to those previously reported for the 
MSP.25,88,92,96 The main problem remained the risk of intraoperative fractures (2.8% 
in Study I), although, in the majority of cases, they were induced by an inappropriate 
surgical technique. All the intraoperative fractures were detected during the primary 
procedure and the fixation could easily be converted to an LGN. Consequently, this 
technical problem did not necessitate any secondary revision procedures. The absence 
of postoperative femoral fractures during the 12-month follow-up implies that some 
of the previously reported early femoral shaft fractures are, in fact, unrecognised 
intraoperative fractures. The problem with femoral shaft fractures will be discussed 
more thoroughly later.  
The good result with the MSP used in the biaxial dynamisation mode in unstable 
trochanteric fractures was confirmed in Study I. The failure rate of 5% compares 
favourably with those in previous studies on the SHS77,88,89,94-96 and is somewhat better 
than those reported for the MSP in the Swedish multicentre study, i.e. 7%97, but not as 
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good as those reported by Lunsjö et al.92, 2.0%, and Watson et al.88, 4%. In clinical 
practice, the differentiation between low trochanteric fractures and high subtrochanteric 
fractures is difficult and may lead to erroneous uniaxial dynamisation in trochanteric 
fractures. This was the situation in the Swedish multicentre study97 where the locking 
set screw was erroneously used in 29 out of 268 patients and contributed to lag-screw 
penetration in 9 patients. The suboptimal results of uniaxial dynamisation in unstable 
trochanteric fractures was also demonstrated in an early study by Lunsjö et al.98 with 
7% lag-screw penetrations. To partly overcome this, a shorter 4-hole MSP was 
introduced with obligatory biaxial dynamisation,99 but the problem of correct 
interpretation and classification of the fracture type in clinical practice still remains.  
In Study III including only patients with unstable trochanteric fractures treated with the 
TGN, the rate of technical failures and the need for revision surgery, 12%, were 
surprisingly high compared to Study I displaying a technical failure rate of only 6% in 
patients with unstable trochanteric fractures treated with the SGN. All but one 
reoperations in Study III were due to secondary lag-screw penetration and cut-out. In 
one patient the lag-screw penetration was seen on the first postoperative X-ray, 
indicating a surgical error. Excluding this case still gives a reoperation rate of 11% and 
the reason for this difference in reoperation rates between Study III (TGN) and Study I 
(SGN) is difficult to interpret. The study populations did not differ regarding age, 
gender or fracture type, nor were there any detectable differences regarding fracture 
reduction and implant position.  
A comparison with other recently published prospective studies including patients with 
unstable trochanteric fractures is difficult to make since most studies include a mixed 
population of patients with stable and unstable trochanteric fractures100-102 or a mixed 
population of patients with trochanteric and subtrochanteric fractures.103 In the RCT by 
Papasimos and co-workers104 comparing cephalomedullary nails (TGN and PFN) with 
SHS (DHS, AMBI hip screw), the reoperation rate was 8% in the nail group and 13% 
in the plate group. In the subgroup of unstable trochanteric fractures in the study by 
Ekström et al.103 comparing a cephalomedullary nail (PFN) with the MSP, 7% of the 
patients in the nail group required a reoperation compared to 1% in the MSP group.  
Other possible explanations for our relatively high failure rate after TGN, besides 
chance, could be insufficient sliding of the TGN lag screw, a suboptimal surgical 
technique with erroneous locking of the lag screw or differing degrees of osteoporosis. 
We are not aware of any previous clinical studies indicating problems with sliding of 
the lag screw in the TGN, but in a biomechanical study, Loch and co-workers105 
investigated the forces required to initiate sliding with different intramedullary nails 
and SHS. Mechanical jamming of the lag screw did not occur with the Gamma nail but, 
in comparison, the Gamma nail required the highest forces to initiate sliding, a finding 
common also for other devices with a short barrel. In order to further analyse the 
failures in Study III, we performed a second survey of the postoperative X-rays in the 
13 patients who experienced a secondary lag-screw penetration/cut-out and we could 
only find one case where jamming of the lag screw may be suspected. This makes 
insufficient sliding and erroneous locking of the lag screw less likely as explanations 
for the worse result for TGN in Study III. Of course, there could be other details in the 
surgical technique that are not detected by our classification of reduction and implant 
position. The existence of a learning curve in acquiring technical skills in orthopaedic 
surgery is well known. The speed of learning is dependent, among other factors such as 
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on surgeon-related ones, operating team experience, surgical volume in the 
department106,107 and the educational atmosphere. Earlier comparative studies between 
the hip compression screw and the Gamma nail have also indicated that the nail was 
associated with significant learning curves.108 However, there were no differences 
concerning the experience of the participating surgeons in Studies I and III that would 
indicate different levels of surgical skill. The surgeons in both studies were all certified 
specialists in orthopaedic surgery and approximately 50% of the operations were 
performed by consultants. Finally, the question regarding differing degrees of 
osteoporosis can not be answered since no assessments of osteoporosis were made in 
our study populations. 
An important additional finding in Study III was a significantly higher reoperation 
rate among patients with 4-part (J-M 5) fractures compared to those with a 3-part 
fracture (J-M 3 and 4), 17% vs 6%. Lunsjö et al. 97 reported a similar finding with 
almost all failures in patients with 4-part fractures (J-M 5). This finding indirectly 
supports the validity of the Jensen-Michaelsen classification14 and also indicates that 
further efforts are needed to reduce the failure rate in the particularly unstable 4-part 
fracture. 
 
Subtrochanteric fractures 
Among the limited number of patients with subtrochanteric fractures in Study I, there 
were no failures in the SGN group, as compared to 2 out of 12 in the MSP group, both 
owing to pronounced medialisation of the femoral shaft. For the limited group of 
subtrochanteric fractures, the failure rate was surprisingly high for the MSP. The two 
reoperations because of technical failures were due to excessive medialisation in 
patients with Seinsheimer type S 2 C fractures, also referred to as the reversed oblique 
subtrochanteric fracture. The explanation may be that the MSP was used in the biaxial 
dynamisation mode. Lunsjö et al.96 reported only 2% of technical failures in 
subtrochanteric fractures when the MSP was used in the uniaxial dynamisation mode. 
However, as previously mentioned, uniaxial dynamisation requires frequent 
radiographic follow-up and readiness for staged dynamisation in a number of cases to 
prevent lag-screw penetration25 and, in clinical practice, the differentiation between low 
trochanteric fractures and high subtrochanteric fractures may be difficult to assess and 
may lead to erroneous uniaxial dynamisation in trochanteric fractures.   
In Study IV including only patients with subtrochanteric fractures treated with the LGN, 
the rate of technical failures and the need for revision surgery, 11%, were of the same 
magnitude as reported in two previous studies on elderly patients with subtrochanteric 
fractures treated with cephalomedullary nails. Robinson et al.109 reported an overall 
reoperation rate of 9% and Ekström et al.110 of 8%. The Seinsheimer type S2C in 
particular has had a high complication rate in patients treated with extramedullary 
implants, including the MSP (Study I),111 but this does not seem to be a problem when 
the fixation is with intramedullary devices. 
 
FRACTURE HEALING COMPLICATIONS 
The main reason for revision surgery in Study II including only patients with stable 2-
part fractures treated with SHS was lag-screw penetration/cut-out, which has also 
been shown to be the predominant cause of revision in most other studies.77,89,94,112  
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The only indication for a reoperation in Study III including only patients with 
unstable 3- and 4-part fractures treated with a TGN was also lag-screw 
penetration/cut-out, a finding which, to some extent, is in contrast with previous 
studies on patients with unstable trochanteric fractures where a combination of 
complications is often reported. These complications include lag-screw 
penetration/cut-out, intra- or postoperative femoral fractures, non-union, including 
breakage or loosening of the osteosynthesis and redislocation with excessive 
medialisation of the femoral shaft, the latter a complication only seen after plate 
fixation.97,99,113 
In Study I including patients with both unstable trochanteric and subtrochanteric 
fractures randomised to treatment with the SGN or MSP, the failures in the SGN 
group were equally divided between lag-screw penetration/cut-out and intraoperative 
femoral fractures. In the MSP group the failures were divided between lag-screw 
penetration/cut-out and redislocation with excessive medialisation of the femoral 
shaft. 
Finally, in Study IV including only patients with subtrochanteric fractures treated with 
the LGN, the main indications for reoperation were similar to those reported from the 
studies by Ekström et al.110 and Robinson et al.,109 i.e. lag-screw penetration/cut-out 
and non-union. Additionally, one patient sustained a fracture close to the tip of the 
nail after a new falling accident.  
The vast majority of the lag-screw penetrations/cut-outs in all studies occurred during 
the early postoperative phase, most often within 6 months, while the non-unions after 
subtrochanteric fractures (Study IV) were diagnosed and treated later, between 6 and 
12 months. As expected, redislocation with excessive medialisation of the femoral 
shaft was seen only in patients with unstable 3-and 4-part trochanteric fractures and 
subtrochanteric fractures treated with plate fixation (MSP; Study I). 
Non-union was seen after subtrochanteric fractures (Study IV) while there were no 
patients with non-union after a trochanteric fracture. 
In summary, the main mode of failure in trochanteric fractures, regardless of 
treatment method, intramedullary or extramedullary, was lag-screw penetration/cut-
out. Additionally, after extramedullary fixation there is a risk for redislocation with 
excessive medialisation of the femoral shaft.  
In subtrochanteric fractures the modes of failure regardless of treatment method, 
intramedullary or extramedullary, were lag-screw penetration/cut-out and non-union. 
Additionally, after extramedullary fixation there is a risk for redislocation with 
excessive medialisation of the femoral shaft. 
 
WOUND INFECTIONS 
As previously mentioned, the cephalomedullary nails have theoretical advantages 
owing to the improved biomechanics with a shorter lever arm leading to a more stable 
fracture construct. Furthermore, the percutaneous insertion technique may result in 
less soft tissue trauma and thereby reduce bleeding and the incidence of infection. 
The theoretical advantages of the percutaneously inserted SGN appeared to be partly 
confirmed in Study I with more limited intraoperative bleeding, although this was not 
confirmed in the form of a reduced need for transfusions, a reduced number of severe 
general complications and a reduced number of wound infections. The reduced 
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number of severe general complications is noteworthy inasmuch as the randomisation 
resulted in a trend towards slightly older patients in the SGN group, i.e. 84.6 years, 
compared to 82.7 years in the plate group. The most probable explanation for these 
findings is the less extensive surgical trauma with the cephalomedullary nail. 
However, a significantly lower rate of wound infections after nail fixation compared 
to plate fixation has not yet been confirmed in the Cochrane meta-analysis RCTs,33 
but somewhat lower infection rates have been reported in single studies.90,100,114,115 
 
FEMORAL SHAFT FRACTURES 
In Study I there was 3% intraoperative fractures in the SGN group, although, in the 
majority of cases, they were induced by inappropriate surgical technique. All the 
intraoperative fractures were detected during the primary procedure and the fixation 
could easily be converted to an LGN. Consequently, this technical problem did not 
necessitate any secondary revision procedures. The absence of postoperative femoral 
fractures during the 12-month follow-up implies that most of the previously reported 
early femoral shaft fractures after the first-generation Gamma nail are, in fact, 
unrecognised intraoperative fractures. An implant with an inherent risk of femoral 
fractures is not optimal, but this risk may be partly due to the specific design of the 
SGN and partly due to an inadequate surgical technique. The length of this first 
generation Gamma nail (200 mm) in combination with 10º of valgus creates a three-
point fixation by the non-elastic implant within the proximal femur, leading to a 
stress concentration in the femur at the distal part of the implant.35,36 In 1992 Leung et 
al. published their findings for a modified Gamma nail with a length of 180 mm and 
only 4º of valgus bend, which resulted in no femoral fractures.90 This modified 
Gamma nail very much resembles the second-generation Gamma nail, the 
trochanteric Gamma nail (TGN), which was used in Study III. 
There were neither intra- nor postoperative fractures of the femur during the one-year 
follow-up in Study III, indicating the TGN with an altered design compared to the 
SGN with a lower valgus bend and a shorter nail, reduces the risk of iatrogenic 
femoral fractures. Moreover, it has been emphasised more and more over the years 
that the nail should be introduced gently without using a hammer and that the distal 
locking screw should be inserted using an adequate and atraumatic technique in order 
to avoid iatrogenic femoral fractures. Our finding of no intra- nor postoperative 
fractures of the femur after the TGN is in conformity with the results of a meta-
analysis from 2009 by Bhandari and co-workers.38 They found that studies conducted 
after the year 2000 did not report a significantly increased risk of femoral shaft 
fractures when the Gamma nail was used. Their objection to a previous systematic 
review116 reporting an overall increased risk of femoral shaft fracture was that the 
previous review did not take into account the effect of implant design or the time 
period during which the studies were conducted. The overall conclusion was that 
previous concerns relating to an increased risk of femoral shaft fracture with the 
Gamma nails had been resolved with the further developed implant design and 
improved surgical learning curve with the device.38 
To the best of our knowledge, there is as yet no prospective study on the third 
generation of Gamma nails, i.e. the Gamma3. 
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SALVAGE PROCEDURES 
The majority of the patients with lag-screw penetrations/cut-outs in Studies I and III 
were treated with a hip arthroplasty, in the majority a THR, which is a logical salvage 
procedure since the penetrating lag crew has most often caused significant erosion of 
the acetabulum. Moreover, in Study III we could report that the patients who received a 
THR showed, as expected, a substantial decline in HRQoL at the 4-month follow-up 
due to their complication and reoperation. The recovery at the 12-month follow-up after 
revision surgery was surprisingly good, showing an improvement in the SMFA indices 
and the EQ-5D index score to a level that was at par with that of patients who had an 
uneventful outcome. The same pattern has been reported in patients with displaced 
femoral neck fractures undergoing a secondary THR after failed internal fixation.117,118 
This finding is supported by previous studies. Cho et al.,119 who concluded that THR 
appears to be a more reliable salvage procedure for failed trochanteric fracture fixation 
regarding functional outcome and pain relief compared to bipolar HA.  D`Arrigo and 
co-workers120 found a significant improvement on comparing the pre- and 
postoperative status after a THR as a salvage procedure for failed treatment of a 
trochanteric fracture in elderly patients.  Similar findings were presented by 
Haidukewych et al.,121 but often with a need for calcar-replacement and long-stem 
implants.   
In Study I, 2 out of 3 patients with excessive medialisation after an MSP were 
successfully treated with a long cephalomedullary nail. In the third case, a primary 
revision to a DCS was done but resulted eventually in a THR. In our opinion, the most 
appropriate solution for patients with excessive medialisation after plate fixation is 
reosteosynthesis with a long cephalomedullary nail. 
In Study IV, one of the patients with a subtrochanteric non-union was treated with 
revision osteosynthesis with DCS and compression and the other with a conversion to 
a THR. This illustrates the two options available. In most cases in elderly patients the 
best choice is, in our opinion, a THR, while a revision osteosyntesis may be 
preferable in the younger patients with better bone quality and a longer life 
expectancy. 
 
SURGICAL TECHNIQUE 
The basic principles of the surgical technique for the SHS/MSP and the 
cephalomedullary nails are quite different. Surgeons experienced in the technique for 
inserting the lag-screw in the SHS or MSP are used to initially positioning the lag-
screw optimally and then applying the side-plate. For the cephalomedullary nails, the 
procedure starts with inserting a nail with a fixed neck angle and then inserting the 
lag-screw. If an optimal guide-wire position is not achieved after proper insertion of 
the nail, the surgeon has to improve the reduction or change to a nail with a different 
neck angle. This may induce surgeons inexperienced in the nailing technique to 
accept a suboptimal lag-screw position, which in turn would contribute to a worse 
outcome. We know from several studies that besides reduction, an optimal lag-screw 
position within the femoral head75-77 is an important factor for determining the 
prognosis.  
We inserted the SGN (Study I), TGN (Study III) and LGN (Study IV) via a proximal 
mini-invasive incision followed by reaming of the medullary canal to 13 mm distally 
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and 17 mm proximally, whereupon the nail was introduced. The nails were 
recommended to be inserted gently by hand and no hammer was allowed for insertion 
of the nail and no awl was allowed for creating the starting point for the locking 
screw. It is important to bear these factors in mind in order to minimise the risk of 
iatrogenic femoral shaft fractures, and our protocol is probably the main reason for 
the low rate of femoral shaft fractures after the SGN (Study I) and no fractures after 
the TGN (Study III).  
In Study I we used the MSP in the biaxial dynamisation mode which allows sliding 
along both the femoral neck and the femoral shaft. In fractures proximal to the entry 
site of the plate barrel, the surgical technique requires that the entry hole for the barrel 
has to be enlarged up to 2.5 cm distally in order to allow axial compression along the 
femoral shaft. To be able to make this decision, the surgeon has to differentiate between 
low trochanteric fractures and high subtrochanteric ones, which may be difficult in 
routine healthcare. This may be a possible explanation for why the MSP is not 
perceived as being as user-friendly as the SHS or the cephalomedullary nails and why 
its use in clinical practice has been limited despite the good results reported in clinical 
trials.  
 
HIP FUNCTION 
The Charnley hip score was used in all studies and the results for each study are 
presented in Table 23.  
 
Table 23. The results for the pain and walking dimensions of the Charnley hip score in 
Studies I–IV. 
 Pain Walking ability 
 4 months 12 months 4 months 12 months 
Study I     
SGN 4.8  5.3  2.5  2.8  
MSP 4.7 5.2 2.6 2.9 
Study II     
DHS 5.1 5.3   
Study III     
TGN 4.6 4.8 3.0 3.4 
Study IV     
LGN 4.5 4.7 3.0 3.7 
 
Although the different study populations were comparable regarding age, mean 82–84 
years, their walking ability before fracture differed, which makes the interpretation of 
walking ability between studies and comparisons with other studies very difficult. In 
Study I 36% of the patients used some form of walking aid already before their fracture. 
The corresponding figure in Study II was 59%, in Study III 55% and in Study IV 43%. 
Generally speaking, reports on pain and functional outcomes for patients with 
trochanteric fractures are sparse in the literature.122 An interesting finding in Study I 
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was that there were no differences regarding hip function according to the Charnley hip 
score on comparing the SGN and MSP. Perhaps this implies that functional outcome 
does not differ substantially on comparing intra- and extramedullary fixation and that 
the main focus for improving the treatment should be on reducing the number of 
technical failures, especially those leading to revision surgery. In several studies,88,97,123-
125 no significant differences between nails and plates are shown, except for the study 
by Ahrengart et al.126 reporting more pain associated with the intramedullary nail and 
the study by Ekström and co-workers103 reporting better walking ability after 6 weeks 
following treatment with a PFN compared to an MSP. 
 
MUSCULOSKELETAL FUNCTION ACCORDING TO THE SMFA 
It is even more difficult to compare the outcome for our patients regarding 
musculoskeletal function according to the SMFA with those of previous studies 
because there are only a few papers reporting longitudinal SMFA data78,127 and only 
one including hip fracture patients. In a recently published retrospective cohort study 
with a mean follow-up of 50 months in 26 multitrauma patients, 13 of whom were 
treated with a sliding hip screw in combination with a retrograde nail and 13 with a 
reconstruction nail, Peskun and co-workers128 reported a Dysfunction Index of 33 in 
both groups and a Bother Index of 37 and 39, respectively. Despite severe injury in a 
multitrauma population, the reported outcome was better than that reported by our 
patients. This finding is probably partly explained by the younger patient population 
(mean age 44 years). 
The results of Study III, including only patients with unstable trochanteric fractures 
treated with the TGN, showed a substantial deterioration in musculoskeletal function as 
demonstrated by the significant increase in the SMFA Dysfunction and Bother Indices. 
The impairment in musculoskeletal function was of the same magnitude in both indices 
of the SMFA. The Dysfunction Index changed from 25 before fracture to 42 at 12 
months and the corresponding values for the Bother Index were 14 and 34. The 
deterioration of these indices was similar to those reported in Study IV including only 
patients with subtrochanteric fractures treated with the LGN. Also this fracture resulted 
in a substantial deterioration in musculoskeletal function, as demonstrated by the 
significant increase in the SMFA Dysfunction and Bother Indices of the same 
magnitude in both indices. The Dysfunction Index changed from 18 before fracture to 
43 at 12 months and the corresponding values for the Bother Index were 10 and 40.  
The deterioration in musculoskeletal function according to the SMFA for the patients 
with unstable trochanteric (Study III) and subtrochanteric (Study IV) fractures was 
reflected by a similar deterioration in HRQoL according to the EQ-5D in both fracture 
types.  
 
QUALITY OF LIFE ACCORDING TO THE EQ-5D 
Patients without severe cognitive dysfunction in all studies reported a significant 
deterioration in HRQoL according to the EQ-5D during the first postoperative year, 
although there were differences in the magnitude. 
The patients with stable trochanteric fractures in Study II experienced deterioration in 
their quality of life during the first postoperative year and the ∆ EQ-5D index score at one 
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year was -0.10 and at two years the survivors had almost regained the same level of 
quality of life as before the fracture. 
In Study III including only patients with unstable trochanteric fractures the ∆ EQ-5D 
index score at one year was -0.28 and in Study IV, including only patients with 
subtrochanteric fractures, the ∆ EQ-5D index score at one year was -0.33. In Study I, 
including both patients with unstable trochanteric and subtrochanteric fractures 
randomised to treatment with SGN or MSP, the ∆ EQ-5D index score at one year was      
-0.15 without any significant differences between the randomisation groups. 
Unfortunately, the follow-up times in Studies I, III and IV were only one year, so we do 
not know for sure if there was an improvement during the second year as in the 
situation after a stable trochanteric fracture (Study II), although it seems less likely.  
Our overall interpretation was that the outcome regarding HRQoL after a stable 
trochanteric fracture is comparably good, while the outcome after an unstable 
trochanteric or subtrochanteric fracture is clearly worse. 
For comparison, patients with undisplaced or displaced femoral neck fractures treated 
with internal fixation have a reduction of the EQ-5D index score during the first year 
after surgery of 0.10 and 0.22, respectively,129 and for patients with displaced femoral 
neck fractures treated with bipolar HA and THR the ∆ EQ-5D index score at one year is  
-0.17 and -0.10 to 0.12, respectively.117,130   
 
ASSESSMENT OF OUTCOME 
Does a quality of life assessment add any valuable information? Up to now there had 
been a very limited number of papers evaluating the HRQOL after trochanteric 
fractures and even fewer using a validated quality-of-life instrument in the assessment. 
There is a growing opinion that measures of quality of life should be used to evaluate 
all healthcare interventions.131 The quality of life assessment serves as a complement to 
conventional outcome measures in orthopaedic surgery, such as fracture-healing 
complications, reoperations and mortality, and also as a complement to disease-specific 
outcome instruments, e.g. scores evaluating hip function. The EQ-5D is brief and easy 
to use in elderly patients132,133 and has been validated in hip-fracture patients.134-136 
Moreover, it also allows combining different dimensions of health to form an overall 
index, such as required for healthcare evaluations137 and for constructing quality-
adjusted life years (QALYs),138 a measure frequently used in cost-effectiveness 
analyses.   
 
NAIL OR PLATE? 
‘Despite the ever increasing literature on the topic of hip fractures, the optimal 
treatment of hip fractures remains unknown and controversial,’ Bhandari et al. 2009.139 
In accordance with this statement, there is no consensus among orthopaedic surgeons 
regarding the treatment of extracapsular hip fractures, i.e. trochanteric and 
subtrochanteric fractures. There is a general agreement on the aims of surgical 
intervention to decrease pain, provide a construct stable enough to withstand early 
transfers, mobilisation and weight-bearing and the objective in the long term of re-
establishing the patient’s prefracture level of function and independence. One of the 
major controversies is whether cephalomedullary nails or extramedullary implants 
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should be used in the different types of trochanteric and subtrochanteric femoral 
fractures. Concerns about the Gamma nails and other cephalomedullary nails have been 
confirmed by early meta-analyses and randomised trials demonstrating an increased 
risk of femoral shaft fractures during and after the operation. Furthermore, other 
incentives for the use of the nails have been debated. In a study by Forte et al. from 
2010140 on a large Medicare series from the years 2000–2002, the authors looked at 
provider factors associated with the use of intramedullary nails for trochanteric 
fractures and found that the use of nails was strongly associated with early-career 
surgeons and surgeon training programmes. Surgeons operating at more than one 
hospital were overrepresented as well as hospitals with teaching status and high-volume 
hip surgery as well. An aspect of a more delicate issue is the use of nails affected by the 
close co-operation of teaching hospitals with manufacturers, and also the Medicare 
payment system may lead to choices of implants in contrast to evidence-based 
medicine principles. Anglen et al.141 conducted a review of the American Board of 
Orthopaedic Surgery database from 1999 to 2006 on nail or plate fixation of 
trochanteric femoral fractures among young surgeons and described a changed pattern 
of practice in favour of nails despite, according to the authors, a lack of evidence in the 
literature supporting this change.  
The largest and latest meta-analysis on this issue, the Cochrane review from 2010,33 
concluded that there is no evidence supporting the use of the Gamma nail or other types 
of cephalomedullary nails as compared to the SHS in trochanteric fractures. Regarding 
the more distal reverse and transverse transtrochanteric fractures and subtrochanteric 
fractures, the conclusion was that the cephalomedullary nails may have advantages over 
the extramedullary devices. Furthermore, pooled data in this review did not show any 
differences between the implants regarding lag-screw penetration/cut-out and non-
union. The authors pointed out that the increased risk of intraoperative and later 
femoral fractures around or below the implant was a particular problem with the nails. 
A discreet reservation regarding this problem was made when discussing nails of more 
modern design and more recent studies. It is noteworthy that recently conducted studies 
showed low or no incidence of intraoperative fracture of the femoral diaphysis and few 
or no subsequent fractures of the femur around the implant.100,101,104  
As previously discussed, the increased risk of femoral shaft fractures when using 
cephalomedullary nails appears to be solved with newer designs of the nails and 
improved surgical technique. The meta-analysis by Bhandari et al. from 200938 
dividing all included studies into three groups in relation to the time when they were 
conducted concludes that previous concerns about an increased femoral shaft fracture 
risk with Gamma nails have been resolved with improved implant design and 
improved learning curves with the device. Earlier meta-analyses and randomised 
trials should be interpreted with caution in the light of more recent evidence. This 
statement is in conformity with our results in Study III using the second-generation 
Gamma nail, the TGN, with no intra- or postoperative femoral fractures. The third and 
most recent generation of Gamma nails, the Gamma3 has not yet been compared in a 
large prospective or randomised trial in patients with trochanteric fractures. 
The use of cephalomedullary nails in patients with subtrochanteric fractures is also 
supported by a recent meta-analysis142 stating that there is evidence indicating reduced 
operating time and a reduced fixation failure rate with the use of intramedullary 
    61
implants. This conclusion is in conformity with the results of Study IV utilising the 
LGN in patients with subtrochanteric femoral fractures.  
As previously discussed, the MSP has displayed good results in clinical studies92,96,97,103 
and yet its use in clinical practice is limited. One major objection has been lacking user-
friendliness and the need for consistent fracture classification in order to use the 
implant optimally.  
In summary, our interpretation of current evidence is as follows: there is sufficient 
evidence supporting the advantages of using cephalomedullary nails in the treatment of 
subtrochanteric fractures. Moreover, cephalomedullary nails of newer generations are 
also safe to use in patients with stable and unstable trochanteric fractures since 
problems with intra-operative and subsequent fractures of the femoral shaft related to 
earlier designs have been solved in recent designs and with a modern atraumatic 
surgical technique. However, whether there are any obvious advantages with the new 
cephalomedullary nails compared to the SHS, including functional outcome and 
HRQoL, will require future large, collaborative studies that are sufficiently powered to 
evaluate the subgroups of patients with stable and different types of unstable 
trochanteric femoral fractures.38,139 
 
THE INFLUENCE OF COGNITIVE FUNCTION ON OUTCOME 
We used the Short Portable Mental Status Questionnaire (SPMSQ) on admission to the 
orthopaedic ward in Study V to identify patients with severe cognitive impairment in a 
cohort of elderly hip fracture patients. According to the recommendation, the definition 
for severe cognitive dysfunction was < 3 correct answers on the SPMSQ (SPMSQ < 3) 
and the baseline and outcome data for these patients were compared to those of patients 
without severe cognitive dysfunction (SPMSQ ≥ 3).47,55 Not surprisingly, patients with 
SPMSQ < 3 were significantly older, were admitted more often from institutions, were 
more dependent in ADL and had an inferior walking ability and a significantly lower 
HRQoL even before the fracture. Severe cognitive impairment, along with male 
gender, was a strong predictor of increased mortality during the first year after the 
fracture. Despite the high mortality rate in this particular group, which probably 
affected the most vulnerable patients, patients with SPMSQ < 3 had a worse functional 
outcome as demonstrated by 36% of the patients being wheel-chair-bound and almost 
39% being totally dependent in ADL functions at the final 12-month follow- up.  
The one-year mortality in hip fracture patients differs significantly between studies 
depending on the inclusion criteria. An increased mortality rate during the first year 
after a hip fracture has been reported previously,143 and, in conformity with our results, 
the rate is higher in men.144,145 The significantly higher one-year mortality rate in 
patients with SPMSQ < 3, as compared to patients with SPMSQ ≥ 3 in our study on 
patients with trochanteric and subtrochanteric fractures, is also in conformity with 
previous studies on patients with femoral neck fractures.87,130 Two recently published 
randomised controlled trials included patients with displaced femoral neck fractures. In 
the first trial, only patients with SPMSQ ≥ 3 were included130 and in the second trial 
only patients with SPMSQ < 3.87 There was a vast difference in outcome on comparing 
the results of the two studies. In the study including patients with SPMSQ < 3, the one-
year mortality rate was 28% and at the one-year follow-up 38% of the patients were 
non-ambulant and 31% dependent in all functions of ADL.87 The corresponding figures 
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in the study including patients with SPMSQ ≥ 3 were 7%, 2% and 1%, respectively.130 
This supports the notion that the cut-off level of < 3 correct answers in the SPMSQ is a 
strong predictor of a poor outcome regarding walking ability, ADL function and 
mortality in all patients with hip fractures, regardless of the specific fracture type.  
The prefracture HRQoL for patients with SPMSQ < 3 was significantly lower than in 
patients with SPMSQ ≥ 3. The prefracture EQ-5D index score, 0.24, for patients with 
severe cognitive impairment was extremely low compared to this age group in the 
Swedish reference population, i.e. 0.7483, and also compared to hip fracture patients 
without severe cognitive dysfunction.129,130 However, it was at the same level as has 
been reported in patients with femoral neck fractures and severe cognitive dysfunction: 
0.26.87 Patients with SPMSQ < 3 showed a continuous deterioration in HRQoL in 
contrast to patients with SPMSQ ≥ 3, who showed significant improvement in the EQ-
5D index score between the 4- and 12-month follow-ups. The same pattern has also been 
demonstrated previously in patients with femoral neck fractures,87,130 probably 
reflecting the natural course of the dementia/cognitive impairment, the difficulty for 
these patients to assimilate rehabilitation and, possibly, inadequate rehabilitation 
resources for this specific patient group. 
Cognitive dysfunction, assessed by the SPMSQ, has previously been reported to be a 
good predictor of mortality.51 However, in the study by Svensson et al.,50 cognitive 
function was a good predictor of independent living at one year, but not of mortality. In 
contrast to our study, the cut-off level of > 7 correct answers was used, i.e. the outcome 
for patients without signs of cognitive dysfunction was compared with those of patients 
displaying different levels of cognitive impairment. Using this higher cut-off level may 
be hazardous since it has been shown that the level of cognitive function fluctuates 
during the hospital stay. These fluctuations in cognitive function are most pronounced 
in patients with moderate and mild cognitive impairment on admission, whereas the 
fluctuation in cognitive function in patients assessed as lucid or severely cognitively 
impaired at admission are usually minor.47 In the study by Strömberg et al.,47 which 
focused on the natural cause of the cognitive state assessed with the SPMSQ in 256 
consecutive hip fracture patients, only approximately 2–3% of patients who were 
severely cognitively impaired (SPMSQ < 3) at admission were lucid at discharge 
(SPMSQ >7). Among patients assessed as lucid (SPMSQ >7) on admission, less than 
2% were cognitively impaired at discharge. Among patients assessed as moderately 
impaired (SPMSQ 3–5) at admission, approximately 70% improved their cognitive 
function during the hospital stay while approximately 5% deteriorated. This fluctuation 
in cognitive function was even more pronounced in the group of patients with mild 
cognitive impairment (SPMSQ 6–7) at admission, more than 80% of whom became 
lucid during their hospital stay.  
What is the risk of not identifying patients with severe cognitive dysfunction in routine 
healthcare? Obviously, it is of major importance for the caregiver to be aware of the 
special needs in this selected patient group.47,50 Firstly, regarding delirium, there are 
several recent intervention studies indicating that the condition can be prevented and 
treated.146-149 Secondly, in patients with displaced femoral neck fractures, the surgeon 
who is unaware of the patient’s cognitive status might choose an inappropriate 
operative method. In contrast to the general opinion that displaced femoral neck 
fractures in the elderly are best managed with an arthroplasty,150 there are studies 
indicating that this may not be true in the selected group of patients with severe 
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cognitive dysfunction,87,151 especially not a THR, where the dislocation rate is 
unacceptably high in cognitively impaired patients.152 Finally, these vulnerable patients 
could receive insufficient nursing care when nurses wrongly perceive them to be 
cognitively alert.53  
There are a number of short mental tests for assessing cognitive function. The most 
widely used one is the Mini-Mental State Examination (MMSE).153 This test includes 
13 items and comprises drawing and manual handling of items. However, when 
conducting this test, a sitting position at a desk is preferable, which is a main drawback 
when assessing hip-fracture patients. The SPMSQ questionnaire includes 10 items and 
is usually administered verbally, although it may be administered in writing to patients 
with hearing deficits. The SPMSQ has been validated as having a similar sensitivity 
and specificity to that of the Mini-Mental State Examination.154 In an overview article 
(Smith et al.),155 the authors concluded that the SPMSQ is quick and easy to administer. 
Its validity was rated as very good and the instrument was considered to be a good 
screening tool. Moreover, the SPMSQ appears to be valid as a severity-rating 
instrument. With regard to the simplicity of the test, interrater reliability was not 
considered to be a problem, and the test-retest reliability has been shown to be very 
good: greater than r =0.80.156 The overall conclusion was that the SPMSQ should 
probably be used more often than it is. 
In conclusion, by using the recommended cut-off level in the SPMSQ and based on one 
assessment at admission to the orthopaedic ward, we could identify hip fracture patients 
with severe cognitive dysfunction and predict their poor outcome regarding walking 
ability, ADL function and mortality. Cognitive dysfunction should be considered a 
major risk factor in the selection of the surgical method and planning for medical and 
nursing care. Previous studies have shown that it may be possible to improve the 
disappointing outcome for this patient cohort by improved rehabilitation regimens.146-
149 A prerequisite for improvement is that patients with cognitive dysfunction are 
identified and an easy-to-use and validated instrument is mandatory for the assessment. 
The results of this study and previous ones on hip fracture patients87,129,130,157 strongly 
suggest that the SPMSQ can be recommended. 
 
LIMITATIONS AND STRENGTHS  
The fact that our interpretation of the SMFA (Studies III and IV) and EQ-5D (Studies I-
V) data was based on our patients’ ability to correctly recall their health status prior to 
the hip fracture may be considered a weakness. However, since a prospective collection 
of preinjury HRQoL data is not possible in trauma studies, we have to rely on preinjury 
recall or a comparison with population figures. But again, our patients’ assessment of 
their preinjury musculoskeletal function according to the SMFA was in conformity 
with that of the North American reference population78,79 and the preinjury EQ-5D index 
score was comparable to the corresponding age groups of the Swedish reference 
population.83  
Study I has some additional limitations. Firstly, in spite of the power analysis prior to 
the study, it turned out to be underpowered. Some of the differences regarding failure 
and reoperation rates, especially in the smaller group of subtrochanteric fractures, did 
not reach statistical significance. On the other hand, the differences in absolute numbers 
were small in the group of trochanteric fractures and the sample size required to 
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statistically secure differences would probably have to exceed what is possible to 
assemble at one institution. Secondly, six patients in the SGN group were operated on 
by a method at variance with the randomisation, in three of them owing to 
intraoperative femoral shaft fractures where a conversion to an LGN was necessary.  In 
the remaining three, the altered choice of implant was due to a misinterpretation of the 
study protocol by the participating surgeons. We believe that keeping these patients in 
the intention-to-treat analysis was more appropriate than to exclude them.  
Another limitation of Study II was that at each follow-up the patients were interviewed 
by phone and only patients reporting problems were scheduled for a follow-up visit 
including a radiographic examination.  
The limited number of patients in Study IV may be considered a weakness. However, 
this type of fracture is rare, constituting only 5−10%25 of all hip fractures and there are 
very few studies with larger study populations.109,110 
In Study V co-morbidities were assessed with the Ceder scale,72 which by definition 
placed all patients with severe cognitive dysfunction in the worst category, C. Owing to 
this fact, we could not evaluate the influence of other co-morbidities on outcome 
including mortality. A different classification, e.g. the ASA classification, would have 
been more appropriate and it would most certainly have been a good predictor of 
mortality, but not necessarily of the worse functional outcome.158 Another weakness of 
Study V was that some of the data were collected in different ways. For patients with 
severe cognitive dysfunction (SPMSQ < 3), the information was collected from a 
proxy. A close relative or caregiver was asked to rate how he or she thinks the patient 
would rate his or her health if he or she were able to communicate. There is generally 
good proxy-patient agreement for concrete, observable variables, e.g. walking ability, 
ADL or living conditions, but not so good for non-observable variables: e.g. pain or 
anxiety/depression. However, in patients with dementia and severe cognitive 
dysfunction, this is the only way to assess the outcome, not only regarding the HRQoL 
but also for variables such as living status, ADL status and the pain and walking 
dimension of the Charnley hip score.39 This approach has also been used previously for 
the EQ-5D in patients with dementia.85,86  
The major strength of all studies in the thesis is that they are all prospective and one 
(Study I) is a randomised controlled trial. Furthermore, all studies include well-defined 
study populations and the outcomes were assessed with validated outcome instruments 
and the two main outcomes measures, SMFA (Studies III and IV) and EQ-5D (Studies 
I-V, except patients with severe cognitive dysfunction in Study V: please see above), 
were self-reported and thereby reduced the risk of bias. The drop-out rates at the 
various follow-ups were acceptable in this fragile age group and not of such magnitude 
that the validity of the conclusions should be jeopardised. 
In summary, we believe our results are representative of our patient populations and 
that our conclusions are valid. 
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CONCLUSIONS 
 
Study I 
The results of the study showed that the SGN displayed good results in both unstable 
trochanteric and subtrochanteric fractures. The limited number of intraoperative 
femoral fractures did not influence the outcome or necessitate further reoperations. 
Moreover, the SGN showed a reduced number of severe general complications and 
reduced the number of wound infections compared to the MSP. The MSP in the biaxial 
dynamisation mode showed a low failure rate in unstable trochanteric fractures but a 
high failure rate when used in the biaxial dynamisation mode in the smaller group of 
subtrochanteric fractures. The negative influence of an unstable trochanteric or 
subtrochanteric fracture on the quality of life was substantial regardless of the choice of 
implant.  
 
Study II 
The results of the study confirm the favourable outcome after a stable trochanteric 
fracture treated with an SHS with a low reoperation rate and a good outcome regarding 
pain at the hip and only limited deterioration in the HRQoL.  
 
Study III 
The results of the study showed that an unstable trochanteric fracture treated with the 
TGN had a substantial negative impact on the patient’s musculoskeletal function as 
well as on the patient’s HRQoL. The need for revision surgery was low in patients with 
a 3-part fracture (J-M 3 and 4), while the reoperation rate among those with a 4-part (J-
M 5) fracture was significantly higher. The by far most common fracture complication, 
i.e. a secondary lag-screw penetration/cut-out, was successfully treated with a THR. 
 
Study IV 
The results of the study showed that a subtrochanteric fracture treated with the LGN 
had a substantially negative impact on the patient’s musculoskeletal function as well as 
on the HRQoL. However, the need for revision surgery was comparatively low. 
 
Study V 
The systematic use of the SPMSQ at admission to the orthopaedic ward identified 
patients with severe cognitive dysfunction and effectively predicted their outcome 
regarding walking ability, ADL function and mortality. The results of this study 
strongly suggest that the SPMSQ can be recommended for use in the elderly hip 
fracture population in routine healthcare.  
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ABSTRACT IN SWEDISH 
Höftfrakturer är en betydande orsak till ökad sjuklighet och dödlighet hos äldre 
personer och Skandinavien har den högsta incidensen av höftfrakturer i världen. En 
höftfraktur är en allvarlig konsekvens av osteoporos som kräver akut kirurgi med hög 
risk för komplikationer och utgör ett hot mot ett fortsatt självständigt liv. De trokantära 
och subtrokantära femurfrakturerna utgör ca 50 % av alla höftfrakturer. 
Det övergripande syftet med avhandlingen var att utvärdera behandlingsresultaten hos 
patienter med stabila trokantära (Studie II), instabila trokantära (Studie I och III) och 
subtrokantära (Studie I och IV) femurfrakturer med avseende på kirurgiska metoder 
inklusive en utvärdering av funktion och hälsorelaterad livskvalitet (HRQoL) enligt 
EQ-5D. Därutöver var syftet att utvärdera om svår kognitiv dysfunktion kunde 
prediktera patienternas resultat avseende funktion, HRQoL och mortalitet (Studie V). 
I en randomiserad studie behandlades 217 patienter, medelålder 84 år, med instabil 
trokantär eller subtrokantär fraktur med antingen en första generationens Gammaspik 
(SGN) eller en Medoff glidskruv/platta (MSP) (Studie I). SGN visade goda resultat vid 
såväl instabila trokantära som subtrokantära frakturer. Dessutom uppvisade SGN ett 
minskat antal allvarliga allmänna komplikationer och infektioner jämfört med MSP. 
MSP i biaxialt dynamiseringsläge uppvisade en låg komplikationsfrekvens hos 
patienter med instabila trokantära frakturer men en högre komplikationsfrekvens i den 
mindre gruppen av patienter med subtrokantära frakturer. 
I en prospektiv kohortstudie inkluderades 148 patienter, medelålder 83 år, med stabil 
trokantär fraktur behandlad med en glidskruv/platta (SHS) (Studie II). Resultaten hos 
dessa patienter bekräftade tidigare publicerade goda resultat med låg reoperations-
frekvens, bra funktionellt resultat och endast en begränsad försämring av HRQoL. 
I en prospektiv kohortstudie inkluderades 117 patienter, medelålder 84 år, med instabil 
trokantär fraktur och som behandlades med andra generationens Gammaspik (TGN) 
(Studie III). Resultaten visade en betydande negativ inverkan på patientens 
muskuloskeletala funktion enligt SMFA och hälsorelaterade livskvalitet enligt EQ-5D. 
Behovet av revisionskirurgi var låg hos patienter med en 3-fragmentsfraktur men 
signifikant högre hos patienter med 4-fragmentsfraktur. Den i särklass vanligaste 
frakturkomplikationen, redislokation av frakturen med följande genomskärning av 
skruven genom lårbenshuvudet, behandlades framgångsrikt med en total 
höftledsplastik. 
I en prospektiv kohortstudie inkluderades 53 patienter, medelålder 82 år, med 
subtrokantär fraktur behandlade med lång Gammaspik (LGN) (Studie IV). Resultaten 
visade en betydande negativ inverkan på patientens muskuloskeletala funktion enligt 
SMFA och hälsorelaterade livskvalitet enligt EQ-5D. Däremot var behovet av 
revisionskirurgi förhållandevis lågt. 
I Studie V inkluderades 213 patienter från Studie I. Resultaten visade att en systematisk 
användning av ett validerat instrument för bedömning av kognitiv funktion, SPMSQ, 
identifierade patienter med svår kognitiv dysfunktion och predikterade effektivt deras 
resultat avseende gångförmåga, ADL-funktion och mortalitet. Resultaten från denna 
studie talar starkt för att SPMSQ kan rekommenderas för användning hos den äldre 
höftfrakturpopulationen inom sjukvården. 
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